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1 List of abbreviations 
AAC    ADP/ATP carrier 
ADP    adenosine diphosphate 
Amp    ampicillin 
APS    ammonium peroxodisulfate 
ATP    adenosine triphosphate 
BN-PAGE   blue native polyacrylamide gel electrophoresis 
bp   base pair 
BSA    bovine serum albumin 
CJs    crista junctions 
CM    crista membrane 
DDM   n-Dodecyl-D-Maltoside 
DHFR   dihydrofolate reductase 
DiSC3(5)   dipropylthiadicarbocyanine iodide 
DTT    dithiotreitol 
dNTP    deoxyribonucleoside triphosphate 
E. coli   Escherichia coli 
ECL   Enhanced chemiluminescence 
EDTA   ethylendiamine tetraacetate 
IMB    inner boundary membrane 
IM   inner membrane  
IMS    intermembrane space 
HA    Haemagglutinin 
HEPES   N-2 hydroxyl piperazine-N´-2-ethane sulphonic acid 
Hsp    heat shock protein 
kDa    kilodalton 
LB    Luria Bertani 
MIM    mitochondrial inner membrane 
MOM    mitochondrial outer membrane 
MOPS   N-morpholinopropane sulphonic acid 
MPP    mitochondrial processing peptidase 
mtHsp   mitochondrial heat shock protein 
MTS   mitochondrial targeting sequence 
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NADH   nicotine amide adenine dinucleotide 
ORF   open reading frame 
OD   optical density 
PAGE   polyacrylamide gel electrophoresis 
PCR    polymerase chain reaction 
PEG    polyethylene glycol 
PK    proteinase K 
PMSF   phenylmethylsulfonyfluoride 
PVDF   polyvinylidene difluoride 
RNasin   ribonuclease inhibitor 
RPM   revolutions per minute  
RT    room temperature 
SAM    sorting and assembly machinery 
SAP    shrimp alkaline phosphatase 
S. cerevisiae  Saccharomyces cerevisiae 
SD   standard deviation 
SDS    sodium dodecyl sulfate 
TBS    TRIS buffered saline 
TCA   trichloroacetic acid 
TEMED   N,N,N‘,N‘-tetramethylene diamine 
TIM    translocase of the inner mitochondrial membrane 
TMD    transmembrane domain 
TOM    translocase of the outer mitochondrial membrane 
TRIS    tris-(hydroxymethyl)-aminomethane 
TX-100   Triton X-100 
v/v    volume per volume 
w/v    weight per volume 
wt    wild type 
ΔΨ   membrane potential  
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2 Summary 
Mitochondria are important organelles that are required for generation of ATP, 
and are also involved in regulation and monitoring various cellular processes. They 
are divided into several sub-compartments, among them is the mitochondrial inner 
membrane (IM), which harbors the highly structured multi-subunit respiratory chain 
complexes. Most of the subunits of these complexes are nuclear-encoded and 
imported from the cytosol into mitochondria. A small group of the subunits of the 
respiratory complexes are synthesized within the organelle and are then directed to 
their proper destination. Components of the respiratory chain complexes from both 
origins are assembled into the mitochondrial IM with the help of various assembly 
factors. The integration of the core subunits of cytochrome bc1 complex (complex III) 
and cytochrome c oxidase complex (complex IV) into the IM is well studied. However, 
the assembly and organization of their supercomplexes are still not completely 
understood.  
This work characterizes a previously uncharacterized yeast protein (ORF 
YDR381C-A) that we named cytochrome c oxidase interacting protein 1 (Coi1). The 
protein was found to be a new regulatory factor that is involved in the assembly of 
complex IV and supercomplexes. The results demonstrated that Coi1 is a small 
mitochondrial IM protein with a single transmembrane segment toward its N-terminus 
whereas the C-terminus faces the intermembrane space (IMS). Deletion of COI1 
leads to a severe growth phenotype on non-fermentable carbon sources, a decrease 
in membrane potential, hampered respiration, and reduced enzymatic activity of 
complex IV. In addition, the steady-state levels of subunits of complexes III and IV as 
well as of the assembled complexes and supercomplexes are reduced. Furthermore, 
Coi1 was found to physically interact with subunits of both complexes, although it 
appears to be a stoichiometric subunit neither of complex III nor of complex IV. Of 
note in absence of Coi1, heme A in complex IV was completely diminished. 
Collectively, this work identifies a novel protein that plays a role in the assembly of 
the mitochondrial respiratory chain supercomplexes. 
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3 Introduction 
Eukaryotic cells are divided into numerous membrane-surrounded compartments 
that form different organelles. To function properly, each organelle requires a specific 
set of proteins in order to functionally contribute to the wide spectrum of biochemical 
processes in the cell. The vast majority of these proteins are nuclear encoded and 
synthesized in the cytosol, whereas very few proteins are encoded by mitochondrial 
or plastid genomes. After or during their synthesis, the nuclear-encoded proteins are 
targeted to their designated destination where they can properly perform their 
function (Neupert and Herrmann, 2007; Soll and Schleiff, 2004). Newly synthesized 
proteins are directed to their target organelles by targeting signals, which are 
recognized by receptors in the cytosol or on the organelle itself. The proteins are then 
translocated across or inserted into the organelle’s membrane (Schnell and Hebert, 
2003). Over the years, our understanding of protein trafficking and organelle 
biogenesis has significantly increased. This knowledge provides us a better 
understanding of crucial cellular processes. 
 
 Structure and function of mitochondria 3.1
According to the endosymbiont theory, ~1.5 billion years ago mitochondria 
evolved from α-proteobacteria, which were taken up through endocytosis by an 
anaerobic primitive eukaryotic cell (Gray et al., 1999). In the course of evolution, the 
host cell transferred the endosymbiont genes to the nucleus to improve its own 
survival chances and to regulate the mitochondrial activity in an oxygen-rich 
environment (Cavalier-Smith, 1987). Mitochondria are present in the majority of 
eukaryotic cells where they form dynamic, tubular network-like structures surrounded 
by a double membrane. The mitochondrial network is not static but constantly 
undergoes processes of fusion and fission (Hoffmann and Avers, 1973; Okamoto and 
Shaw, 2005). The two mitochondrial membranes give rise to four sub-compartments. 
The outer membrane (OM), which separates the organelle from the surrounding 
cytoplasm, and the inner membrane (IM), which separates the inner membrane 
space (IMS) from the matrix. Mitochondrial proteins are mainly encoded in the 
nucleus (>99%) and synthesized as precursor proteins on cytosolic ribosomes before 
their import into the mitochondria. However, a few mitochondrial proteins are also 
encoded by the mitochondrial genome in the organelle´s matrix. Most of these 
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mitochondrially-encoded proteins are very hydrophobic IM proteins. Thus, their 
synthesis in the cytosol and the ensuing transport to the mitochondria via the 
aqueous environment in the cytosol might pose an immense problem to the cell. This 
drawback is circumvented by co-translationally inserting these proteins into the inner 
membrane from the matrix (Neupert and Herrmann, 2007; Soll and Schleiff, 2004).  
Mitochondria play a fundamental role in the generation of energy by oxidative 
phosphorylation. They are further required for various metabolic pathways such as 
the tricarboxylic acid cycle, β-oxidation of fatty acids, the metabolism of amino acid 
and lipids, the biosynthesis of heme cofactors and iron-sulphur clusters. In addition to 
their metabolic function, mitochondria also assist in signaling and act as a central 
regulatory element of apoptosis, autophagy, and aging (Lill, 2009; Pagliarini et al., 
2008; Schmidt et al., 2010; Youle and Karbowski, 2005). Taken together, 
mitochondria play a prime role in many cellular processes. Their importance is further 
highlighted by a series of disorders in humans that are caused by mitochondrial 
dysfunction (Scheffler, 2001).  
 
 Mitochondrial protein translocation 3.2
3.2.1 Import of nuclear encoded proteins  
Most mitochondrial proteins are encoded by the nuclear DNA and synthesized in 
the cytosol. The precursor proteins are imported from the cytosol into mitochondria in 
a post-translational or co-translational manner (Fujiki and Verner, 1991, 1993). The 
post-translational import of nuclear-encoded proteins into the mitochondria is a widely 
accepted concept (Ahmed and Fisher, 2009; Borgese et al., 2007). Most likely, 
cytosolic chaperones stabilizes the precursor proteins during or just after their 
translation to protect them from aggregating until they have reached their final 
destination (Neupert and Herrmann, 2007). The precursor proteins are targeted to 
the mitochondria by recognition sequences. Proteins designated to the IM, the IMS, 
or the matrix often contain a cleavable N-terminal signal sequence, which is about 
10-80 amino acids long (Prokisch et al., 2006). The presequence directs the 
precursor protein all the way to the matrix where it is usually cleaved off by the 
mitochondrial matrix processing peptidase (MPP) to complete the import of the 
protein. As an alternative to a cleavable N-terminal signal, the vast majority of 
mitochondrial OM proteins and also some proteins found in the mitochondrial IM and 
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the IMS contain internal targeting sequences where the targeting signal remains part 
of mature protein (Neupert and Herrmann, 2007). 
 
 
Figure 3.1 Protein translocation machineries in mitochondria. Nuclear encoded proteins 
are imported into the mitochondria by various import machineries present in the OM and the 
IM. The precursor proteins are recognized by receptors on the outer membrane and further 
sorted by different pathways to their final destination. Most of the proteins enter the 
mitochondria through the TOM complex. The biogenesis of β-barrel proteins requires small 
Tim chaperones present in the IMS and the TOB machinery that inserts the β-barrel proteins 
into the OM. α- helical single and multi-span proteins are recognized by OM surface receptor 
proteins, and the MIM machinery inserts them into the OM. Presequence containing proteins 
are inserted into the IM or imported into the matrix by the TIM23 complex. For the import into 
the matrix, the TIM23 complex works together with the PAM module. When presequence-
containing proteins reach the matrix, their presequence is cleaved off by MPP. Carrier 
proteins are transported with the help of small Tim chaperones and are inserted into the IM 
by the TIM22 machinery. Proteins containing cysteine-rich signals are retained in the IMS by 
oxidation through the MIA system. Nearly all precursor proteins destined for the IMS, the IM, 
or the matrix are imported in membrane potential (ΔΨ)-dependent fashion.  
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Mitochondria contain seven main import machineries that are involved in the 
translocation of different types of proteins. Three translocase machineries, namely 
the translocase of the outer mitochondrial membrane (TOM) complex, the 
topogenesis of mitochondrial outer membrane β-barrel proteins (TOB) complex (also 
known as sorting and assembly machinery, SAM), and the mitochondrial import 
(MIM) complex are found in the OM. Almost all mitochondrial precursor proteins are 
recognized on the mitochondrial surface by the receptor proteins of the TOM complex 
(Tom20, Tom22 and Tom70) and translocated through a pore formed by the central 
component of the TOM complex, Tom40 (Chacinska et al., 2009; Neupert and 
Herrmann, 2007). The TOB complex facilitates the membrane insertion of β-barrel 
proteins, while the MIM complex is involved in the import of single- and multi-span α-
helical proteins of the OM. The mitochondrial IM harbors four import machineries: the 
translocase of the inner membrane (TIM) 22 complex, the TIM23 complex, the 
oxidase assembly 1 (OXA1) complex, and the mitochondrial intermediate space 
assembly protein (MIA) complex (Fig 3.1). 
Precursor proteins with a cleavable presequence are translocated across the OM 
by the TOM complex and handed over to the TIM23 complex which inserts them into 
the IM or transports them to the matrix. For the import into the matrix, the TIM23 
complex interacts with the presequence translocase-associated motor (PAM) 
machinery. Once the precursor proteins arrive in the matrix, their presequence is 
cleaved off by MPP (Becker et al., 2012; Dudek et al., 2013; Prokisch et al., 2006; 
van der Laan et al., 2010). Another class of proteins with a cleavable N-terminal 
signal is first imported to the matrix in TIM23- and PAM-dependent manner and 
afterwards inserted into the IM by Oxa1. This process is also known as the 
conservative sorting pathway (Fig 3.2) (Bohnert et al., 2010; Hell, 2008).  
Precursor proteins containing an internal targeting sequence use different import 
pathways. Multi-span carrier proteins are translocated first by the TOM complex and 
are then imported into the IM with the assistance of the TIM22 machinery (Brix et al., 
1999). IMS proteins containing cysteine rich motifs are imported by TOM complex 
and retained in the IMS by forming intermolecular disulfide bridges. The disulfide 
bridge formation is catalyzed by the MIA complex (Chacinska et al., 2004; Hell, 
2008).  
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Mitochondria contain several chaperones to keep proteins that are currently 
being imported from aggregating. In the IMS, this job is performed by the small Tim 
chaperone complexes (Tim9/Tim10 and Tim8/Tim13). Additionally, various 
chaperones present in the matrix support protein folding (Ssc1, Mdj1, Hsp60/Hsp10, 
Hsp78, and Hep1) (Chacinska et al., 2009; Davis et al., 2007).  
 
Figure 3.2 Various pathways for the membrane integration of respiratory components. 
Precursor proteins of the respiratory chain complexes are encoded by both nuclear and 
mitochondrial DNA. Precursor proteins of nuclear origin are recognized by the receptors on 
the OM and imported through the TOM and TIM23 complexes. Mitochondrially-encoded 
precursor proteins are synthesized in the matrix and inserted into the IM in a co-translational 
manner. To achieve this, the mitochondrial ribosomes are bound to the OXA1 machinery. 
Some nuclear-encoded precursor protein are first imported into the matrix by the TIM23/PAM 
complex and then further inserted into the IM by the OXA1 machinery. This import pathway is 
also known as conservative sorting. After the membrane insertion of precursor proteins, they 
are assembled into functional complexes.  
 
3.2.2 Membrane insertion of mitochondrially-encoded proteins  
The mitochondrial genome of yeast encodes eight proteins. Among them, seven 
are hydrophobic subunits of the respiratory chain complexes, which are embedded in 
the IM (Fox, 2012; van der Laan et al., 2010). These proteins are translated on 
mitochondrial ribosomes associated directly with the membrane and are inserted into 
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the IM in a co-translational fashion with the help of the assembly factor Oxa1. Oxa1 is 
also required for assembly of some nuclear-encoded proteins as mentioned above 
(Fig 3.2) (Bohnert et al., 2010; Fox, 2012; Hell et al., 2001). Oxa1 inserts proteins 
containing signatures of negatively charged amino acids into the IM, and this process 
is membrane-potential dependent (Herrmann et al., 1997). Whereas Oxa1 interacts 
directly with ribosomes, additional factors like Mba1 and Mdm38 are also involved in 
attaching the translating ribosomes to the IM (Fig 3.2) (Hell et al., 2001; Ott et al., 
2006). 
 
 Oxidative phosphorylation system  3.3
Under aerobic conditions, eukaryotic cells generate energy in the form of ATP 
through the process of oxidative phosphorylation in mitochondria. The mitochondrial 
IM forms heavily folded structures known as cristae. Each crista harbors several 
copies of respiratory chain components such as NADH dehydrogenase (complex I), 
succinate dehydrogenase (complex II), cytochrome bc1 (complex III), cytochrome c 
oxidase (complex IV), and F1Fo-ATP synthase (complex V) (Boekema and Braun, 
2007). 
The oxidative phosphorylation system is powered by electrons derived from the 
citric acid cycle intermediates NADH and succinate. Complex I catalyzes the 
oxidation of NADH to NAD+ and releases four protons into the IMS during the 
reaction (Fig 3.3). In yeast, complex I is absent and the oxidation of NADH is carried 
out by Nde1, Nde2, and Ndi1 (Fig 3.3B). This reaction does not release protons into 
the IMS (Fig 3.3A) (Grandier-Vazeille et al., 2001). Complex II generates electrons by 
oxidizing succinate to fumarate. The electrons are passed from complex I and 
complex II to coenzyme Q (CoQ) which delivers them to complex III, where they are 
transferred to cytochrome c (Cyt C). Complex III not only relays the electrons from 
CoQ to Cyt C but also pumps protons into the IMS during this process. Complex IV is 
the final enzyme of the electron transport chain and accepts electrons from Cyt C. 
These electrons are then utilized to reduce oxygen molecules to water. This also 
leads to an accumulation of four additional protons in the IMS. As several of the 
respiratory chain complexes pump protons to the IMS, the electron flux is coupled to 
the generation of a proton gradient (Δψ) across the mitochondrial IM. This proton 
gradient is used as a motive force for  complex V, which converts it into energy 
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stored in a chemical bond through phosphorylation of ADP to ATP (Fig 3.3) (Chaban 
et al., 2014; Saraste, 1999; Yoshida et al., 2001). 
 
Figure 3.3 Oxidative phosphorylation system in mitochondria based on the fluid 
model. The mitochondrial IM harbors different enzyme complexes involved in oxidative 
phosphorylation. (A) The mammalian respiratory chain is composed of NADH 
dehydrogenase (CI), succinate dehydrogenase (CII), cytochrome bc1 (CIII), and cytochrome 
c oxidase (CIV). These complexes synchronize electron transport from one complex to 
another leading to the reduction of O2 to H2O as the final outcome. With the exception of 
complex II all other complexes generate proton flux across the IM during this process. The 
proton gradient is further utilized by the ATP synthase (CV) in production of energy in the 
form of ATP. (B) The oxidative phosphorylation system in S. cerevisiae consists of 
complexes II-IV and the F1-F0 ATP synthase. A multimeric complex of Nde1, Nde2, and Ndi1 
replaces complex I of higher eukaryotes. In both systems, coenzyme Q (CoQ) and 
cytochrome c (Cyt C) are involved in electron transport between the complexes. These 
schematic representations are based on the fluid model (Hackenbrock et al., 1980). 
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 Composition and structure of the respiratory chain complexes  3.4
Yeast mitochondria synthesize eight proteins: cytochrome b (Cob) of complex III; 
Cox1, Cox2, and Cox3 as core components of complex IV; Atp6, Atp8, and Atp9 of 
complex V, and Var1 which is a ribosomal protein. Complex II is the only respiratory 
chain complex which does not contain mitochondrially-encoded proteins (Fox, 2012; 
Mick et al., 2011). 
 
3.4.1 Assembly of the cytochrome bc1 complex  
Cytochrome bc1 complex (complex III) is an essential component of the electron 
transport chain. It transfers electrons from CoQ to Cyt C, and for each transferred 
electron, one proton is transported to the IMS. The catalytic core consists of the 
mitochondrially-encoded Cob with two heme B molecules (low potential bL and high 
potential bH), the nuclear-encoded proteins cytochrome c1 (Cyt1) that binds heme C, 
and the Rieske iron-sulphur protein (Rip1) that harbors a 2Fe-2S prosthetic group. 
Apart from the catalytic core, complex III contains seven additional subunits: Cor1, 
Cor2, Qcr6, Qcr7, Qcr8, Qcr9, and Qcr10 (Hunte et al., 2000; Smith et al., 2012). For 
the proper function of complex III, the assembly of nuclear- and mitochondrially-
encoded proteins are arranged in a coordinated fashion starting with Cob, which is 
the sole mitochondrially-encoded subunit. In the next step, as a part of the early 
assembly subunit, Qcr7 and Qcr8 are added. The intermediate assembly complex is 
formed by Cor1, Cor2, Cyt1, and Qcr6 together with the early assembly subunits. The 
assembly of complex III is finished with the addition of Qcr9, Qcr10, and Rip1. 
Assembly factors such as Cbp3, Cbp4, Cbp6, and Bca1 play a role in the early 
assembly, whereas insertion and assembly of Rip1 is performed by the assembly 
factors Bcs1 and Mzm1 (Nobrega et al., 1992; Smith et al., 2012). Complex III is 
completely functional in a homo-dimer state, which forms supercomplexes with 
complex IV for efficient electron transport (Dudkina et al., 2010; Hunte et al., 2000). 
 
3.4.2 Assembly of cytochrome c oxidase 
Cytochrome c oxidase (complex IV) is the terminal enzyme in the electron 
transport chain that oxidizes Cyt C to reduce molecular oxygen to water. In yeast, 
cytochrome c oxidase forms a complex comprised of twelve subunits. The core 
subunits of the complex, Cox1, Cox2, and Cox3 are encoded by mitochondrial DNA 
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(Castresana et al., 1994). Cox1 and Cox2 contain cofactors that are required for their 
catalytic activity. Cox1 has a heme a and a bimetallic heme a3-copper (CuB) site, 
whereas Cox2 has a binuclear copper ion site (CuA) (Mick et al., 2010; Soto et al., 
2012). In addition to the core components, complex IV comprises nine nuclear-
encoded subunits: Cox4, Cox5a/b, Cox6, Cox7, Cox8, Cox9, Cox12, Cox13, and 
Cox26 (Geier et al., 1995; Levchenko et al., 2016; Soto et al., 2012; Strecker et al., 
2016). 
The assembly of complex IV is not completely understood, but it is believed to be 
modulated in a sequential pathway with a number of assembly intermediates. The 
assembly of complex IV is initiated by the Cox1 translation activators Pet309 and 
Mss51 (Fox, 2012; Stiburek et al., 2005). Oxa1 co-translationally inserts Cox1 into 
the IM in association with the assembly factors Cox14, Coa1, Coa3, and Shy1, 
thereby forming the early assembly complex (Barrientos et al., 2004; Mick et al., 
2011; Mick et al., 2010). Coa1 and Shy1 interact with the early assembly complex 
leading to disassociation of Mss51, which acts as a negative regulatory loop of Cox1 
translation (Mick et al., 2011). Prior to the assembly of the nuclear-encoded subunits, 
cofactors such as heme and metal ions are incorporated into the early assembly 
complex containing Cox1. The first nuclear-encoded subunits to join the growing 
complex, Cox5 and Cox6, form a sub-complex before inserting into the early 
assembly complex (Mick et al., 2011; Stiburek et al., 2005). Matured Cox2 and Cox3 
are exported by Oxa1 and associate with the Cox1, Cox5, and Cox6 sub-complex, 
but the sequential order still remains unclear. Cox7, Cox8, and Cox9 form another 
sub-complex prior to their incorporation into complex IV. Finally, the structural 
subunits Cox12 and Cox13 join the holo-complex (Church et al., 2005). Cox13 is 
assembled by the supercomplex assembly proteins Rcf1 and Rcf2 (Vukotic et al., 
2012).  
 
 Respiratory supercomplexes  3.5
3.5.1 Organization of supercomplexes  
Mitochondria are dynamic structures that reorganize themselves according to 
variable cues such as external stress or upon a change of nutrient source. 
Respiratory chain complexes arrange and distribute themselves into individual   
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complexes or into supercomplexes. Over the years, the organization of these 
supercomplexes were summarized in three different models namely known as fluid, 
solid, and plasticity model. The fluid model treats the respiratory chain complexes as 
individual respiratory units without any physical interactions between each other. In 
this model, the electron carriers move freely within the lipid membrane (Fig 3.3) 
(Hackenbrock et al., 1986; Hackenbrock et al., 1980). In contrast to the fluid model, 
the solid model states that the respiratory complexes are arranged for more efficient 
transfer of electrons in larger structures formed from complexes I-IV (higher 
eukaryotes) or complexes III-IV (yeast) (Fig 3.4) (Lange and Hunte, 2002; Lenaz, 
2001; Schägger and Pfeiffer, 2000). In mammals and plants, supercomplexes, which 
are also known as respirasome, are formed from complex I, two copies of complex 
III, and one to four copies of complex IV (I+III2+IV1-4) (Dudkina et al., 2010; Eubel et 
al., 2003; Schägger and Pfeiffer, 2000). 
 
Figure 3.4 Schematic representation of respiratory chain complexes according to the 
solid model. In the solid model the respiratory chain complexes in higher eukaryotes are 
composed of complex I, III, and IV and in yeast of complex III and IV. The electrons are 
transferred with the help of coenzyme Q (CoQ) and cytochrome c (Cyt c), which reside in the 
inner membrane or in the IMS, respectively. This model is based on Schägger et al 2001. 
 
In yeast, supercomplexes are formed from two copies of complex III and one to two 
copies of complex IV (III2+IV1-2) (Chaban et al., 2014; Cruciat et al., 2000; 
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Heinemeyer et al., 2007; Mileykovskaya et al., 2012; Schägger and Pfeiffer, 2000). 
Complex V in yeast forms dimers, and this dimerization is important for cristae 
formation (Arnold et al., 1998; Gavin et al., 2004). So far, no study has shown 
complex II as being part of a supercomplex.  
Previous experiments using isolated supercomplexes could show electron 
transfer supporting the solid model over the fluid model. In addition, the migration 
behaviour of the complexes when analysed by blue native gel electrophoresis points 
towards the solid model rather than the fluid model. However, even in these 
experiments, the supercomplexes were stable only in the mild detergent digitonin, 
whereas in other detergents such as DDM only the individual complexes were 
detectable (Schagger, 2001a; Schägger and Pfeiffer, 2000). 
 
 
Figure 3.5 Schematic representation of the plasticity model. The plasticity model is a 
hybrid of both the fluid and the solid model. The respiratory chain complexes are arranged 
both in individual complexes (fluid model) and in the aforementioned supercomplexes (solid 
model) in different combinations. The question mark indicates a putative association with the 
supercomplexes. The plasticity model is based on Schägger et al 2001 and Acín-Pérez et al 
2014.  
 
An in vivo evidence for supercomplex formation was lacking until recently when the 
dynamic assembly of complexes and supercomplexes was monitored in a 
mammalian cell line. Two independent groups investigated the assembly of 
respiratory chain complexes by metabolic labeling of mitochondrially-encoded 
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proteins. The group of Acín-Pérez observed the initial assembly of single complexes, 
and after a long incubation period, supercomplexes were also observed (Acin-Perez 
and Enriquez, 2014; Acin-Perez et al., 2008). Similar experiments performed by the 
group of Ugalde showed partial assembly of complex I, which was completely 
assembled upon its interaction with complex III and IV (Acin-Perez and Enriquez, 
2014; Moreno-Lastres et al., 2012). These experiments led to a new model, termed 
plasticity model, which includes complexes and supercomplexes being arranged in 
both fluid and solid models (Fig 3.5) (Acin-Perez and Enriquez, 2014). Although 
these aforementioned models came as a result of investigations mainly in 
mammalian systems, to a large extent they can also explain organization of 
supercomplexes in yeast cells. 
 
3.5.2 Interface between complexes III and IV within their supercomplexes  
A pseudo-atomic model of supercomplexes was constructed with the help of X-
ray structures of yeast cytochrome c reductase and cytochrome c oxidase from 
bovine heart (Heinemeyer et al., 2007; Schägger and Pfeiffer, 2000; Tsukihara et al., 
1996). Monomeric complex IV was surrounded by two complex III units, one on each 
side of the complex IV. The predicted interaction interface consists of the complex IV 
subunits Cox1, Cox2, Cox3, Cox4, Cox5, Cox7, and Cox8 together with the complex 
III subunits Cob, Cyt1, Qcr6, Qcr7, Qcr8, and Qcr9 (Heinemeyer et al., 2007). 
Previous experiments could already show an interaction of Cox1, Cox2, and Cox3 (all 
complex IV) with elements of complex III (Heinemeyer et al., 2007; Stuart, 2008; 
Winge, 2012).  
 
3.5.3 Physiological relevance of supercomplexes 
For the efficient function of the oxidative phosphorylation system, the respiratory 
chain complexes need to be arranged into a higher-organization state, which is thus 
of crucial functional importance. In terms of physiology, supercomplexes play an 
important role in substrate channeling, complex stability and sequestration of reactive 
intermediates (Schagger, 2001b). Association of complexes III and IV (I, III and IV in 
higher eukaryotes) improves the electron transfer rate as it reduces the distance that 
cytochrome c has to cover for the electron transfer between complex III and IV (Fig 
3.5). The distance between the binding sites of cytochrome c in complex III and IV 
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are less than 6 nm in the yeast respirasome and less than 10 nm in the bovine 
respirasome, which improves the enzyme kinetics of the oxidative phosphorylation 
(Althoff et al., 2011; Chaban et al., 2014; Dudkina et al., 2011; Mileykovskaya et al., 
2012).  
Furthermore, the formation of supercomplexes increases the stability of the 
respiratory chain complexes and the capability of protein insertion into the IM. The 
dimerization of ATP synthase modulates the cristae structure and creates membrane 
curvature, which facilitates in turn supercomplex assembly and leads to optimal 
proton transport for further ATP synthesis (Davies et al., 2012). The characterization 
of cells with mutated forms of respiratory chain subunits supports a role of 
supercomplexes in maintaining the stability of the individual respiratory chain 
complexes. Mutations in subunits of complex III or IV destabilize complex I, 
suggesting that formation of complex III and IV is required for the stability of complex 
I in mammals. Interestingly, also in the bacterial system Paracoccus denitrificans the 
assembly of complex I is improved by rearrangement of I+III4+IV4 supercomplexes 
(Genova and Lenaz, 2014). 
In summary, there are many indications that supercomplex formation plays an 
important role as it (1) increases electron transfer, (2) reduces the release of reaction 
oxidative species, (3) acts as a regulatory unit in respiration, (4) maintains the 
ultrastructure of the inner membrane, and (5) plays a role in increasing the stability of 
the respiratory chain complexes.  
 
3.5.4 Stability and function of supercomplexes  
Many studies were undertaken to understand the assembly and stability of the 
single respiratory chain complexes and of their supercomplexes. Experiments with 
cells lacking different subunits of the respiratory chain complexes revealed that not all 
the subunits are essential for supercomplex formation. For example, it was reported 
that Qcr9 or Rip1 destabilize supercomplexes formed by complex III and IV, whereas 
Qcr6, Qcr10 (complex III), Cox8, Cox9, Cox12, or Cox13 (complex IV) are required 
for supercomplex formation (Cruciat et al., 2000; Winge, 2012). Interestingly, the 
phospholipid cardiolipin was found to play a crucial role in the assembly and stability 
of supercomplexes (Pfeiffer et al., 2003). Cardiolipin was found at the interaction 
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interface between complex III and IV, where it associates with Cox3 (complex IV) and 
Cob (complex III). The loss of cardiolipin destabilizes the yeast supercomplex III-IV, 
but has no effect on complex V (Pfeiffer et al., 2003; Schägger, 2002). Along this line, 
an instability of complex IV in the respirasome (I1III2IV1-4) was observed in cells from 
human patients with a mitochondrial dysfunction caused by a mutation in the 
gene taffazin, which is required for cardiolipin remodeling. Taken together, altered 
cardiolipin levels specifically affect the interaction of complex III and IV both in yeast 
and human supercomplexes (McKenzie et al., 2006).  
 
3.5.5  Assembly factors of the supercomplexes 
A group of proteins, which are not directly associated with the electron transport 
chain, can influence the assembly of supercomplexes. Among these proteins is also 
a major isoform of the ADP/ATP carrier, namely Aac2, residing in the mitochondrial 
IM. This protein associates in yeast cells with complex III-IV supercomplexes and 
plays a role for their stability (Claypool et al., 2008; Dienhart and Stuart, 2008). 
ADP/ATP carrier proteins are crucial for the exchange of ADP and ATP across the 
IM. In addition to Aac2, two assembly factors of complex IV, Shy1 and Cox14, are 
also involved in formation of complex III-IV supercomplexes in yeast (Barrientos et 
al., 2004; Glerum et al., 1995; Mashkevich et al., 1997; Stuart, 2008). These proteins 
are involved in the maturation of Cox1 and also physically interact with complex III-IV 
supercomplexes. While the exact function of this association is unknown, one 
assumption is that these factors associate with intermediate assembly forms of the 
supercomplexes (Winge, 2012). Recently, several groups have identified and 
characterized two additional proteins, known as respiratory supercomplex factor (Rcf) 
1 and 2, which directly interact with complex IV and play a role in the stability of the 
supercomplexes (Strogolova et al., 2012). Reduced levels of the III2IV2 supercomplex 
and decreased activity of complex IV were observed in cells lacking Rcf1. These 
phenotypes were even more severe in the absence of both Rcf1 and Rcf2. Of note, 
monomeric levels of complex IV were not affected by the loss of Rcf1. However, the 
assembly of a subunit of complex IV, Cox13, was hampered in this mutant, which led 
in turn to a reduced assembly of the III2IV2 supercomplex (Chen et al., 2012; 
Shoubridge, 2012; Strogolova et al., 2012; Vukotic et al., 2012). 
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Despite of the aforementioned progress our understanding of the assembly of the 
respiratory chain complexes and their supercomplexes, a comprehensive picture of 
the factors involved and their contribution is still missing. 
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4 Aim of the study  
For the proper function of oxidative phosphorylation in yeast cells, the respiratory 
chain complexes arrange themselves into supercomplexes of complexes III and IV. 
This study aims to characterize the novel yeast protein Coi1 (ORF YDR381C-A), 
which was found to play a role in the assembly of the respiratory supercomplexes.  
 
Specifically, the following questions will be addressed:  
I. What are the structural and topological characteristics of Coi1? 
II. What are the interaction partners of Coi1?  
III. What is the molecular function of Coi1?  
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5 Materials and methods  
 Materials  5.1
5.1.1  Media  
All the media, carbon source and amino acid stock solutions, were autoclaved 
separately prior to use. Carbon source such as glucose, galactose, and glycerol were 
added to a final concentration of 2% (v/v). For synthetic media, amino acids (from 
100x stock) were used for specific auxotrophic selection markers. The table below 
summarizes the media used in this study. 
 
Table 1: Media for S. cerevisiae 
Media Composition 
YP media 
2% (w/v) bacto peptone, 1% (w/v) yeast extract, 
2% (v/v) carbon source, pH adjusted to 5.5 with 
NaOH 
Lac media 
0.3% (w/v) yeast extract, 0.05% (w/v) glucose, 
0.05% (w/v) NaCl, 0.1% (w/v) KH2PO4, 0.1% (w/v) 
NH4Cl, 0.06% (w/v) MgCl2∙6H2O, 0.05% (w/v) 
CaCl2∙2H2O, 2.5% (v/v) lactic acid 80%, 0.8% 
(w/v) NaOH, pH adjusted to 5.5 with NaOH 
Synthetic (S) media 
0.19% (w/v) yeast nitrogen base without 
ammonium sulfate, 0.5% (w/v) ammonium sulfate, 
0.0055% (w/v) adenine sulfate, 0.0055% (w/v) 
uracil, 2% (v/v) carbon source,1% (v/v) amino acid 
stock solution, pH adjusted to 5.5 with NaOH. 
YP agar 
2% (w/v) bacto peptone, 1% (w/v) yeast extract, 
2% (w/v) agar, 2% (w/v) glucose or 3% (v/v) 
glycerol, pH adjusted to 5.5 
S agar 
2% (w/v) agar, 0.19% (w/v) yeast nitrogen base 
without ammonium sulfate, 0.5% (w/v) ammonium 
sulfate, 0.0055% (w/v) adenine sulfate, 0.0055% 
(w/v) uracil, 2% (v/v) carbon source,1% (v/v) 
amino acid stock solution, pH adjusted to 5.5 with 
NaOH. 
D-Glucose stock solution 40% (w/v) D-glucose 
Glycerol stock solution 100% glycerol 
D-Galactose stock solution 40% (w/v) D-galactose 
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100X amino acid stock 
0.2% (w/v) arginine, 0.4% (w/v) tryptophan, 1% 
(w/v) leucine, 0.4% (w/v) lysine, 0.2% (w/v) 
histidine, 0.6% (w/v) phenylalanine, 0.2% (w/v) 
methionine 
 
Table 2: Media for E. coli 
Media Composition 
LB medium 
1% (w/v) bacto-tryptone, 0.5% (w/v) yeast extract 
and 0.5% (w/v) NaCl in sterile H2O, pH 7.0.  
LB agar LB media + 2 % (w/v) agar 
LB medium with ampicillin 
Ampicillin stock solution was made of 100 mg/ml 
in H2O and sterilize filtrated. LB medium was 
supplemented with a final conc. of 100 μg/ml 
ampicillin. Ampicillin stock solution was added to 
autoclaved medium or agar solutions only when 
solutions were below 50°C. 
 
5.1.2 Buffers  
The tables below summarize the buffers used in this study.  
 
Table 3: Buffers for agarose gel electrophoresis 
 Name Composition 
1×TAE buffer 
40 mM tris-base, 1.14 ml/l acetic acid, 1 mM 
EDTA, pH 8  
10× DNA loading dye 
6% (v/v) glycerol, 0.05% (w/v) bromophenol 
blue, 0.05% (w/v) xylenecyanol 
 
 Table 4: Buffers for small scale isolation of plasmid from E. coli cells 
Name Composition 
E1 50 mM Tris-HCl, 10 mM EDTA, 100 μg/ml RNase A 
E2 200 mM NaOH, 1% (w/v) SDS dissolved in H2O 
E3 
3 M potassium acetate, pH 5.5 adjusted with acetic 
acid 
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Table 5: Buffers for polymerase chain reaction  
Name Composition 
10× Pfu buffer with 
MgSO4 
100 mM (NH4)2SO4, 100 mM KCl, 1% (v/v) Triton X-
100, 1 mg/ml BSA, 20 mM MgSO4, 200 mM Tris, pH 
adjusted to 8.8 with HCl 
10×Taq buffer with 
(NH4)2SO4 
200 mM (NH4)2SO4, 0.1% (v/v) Tween20, 750 mM 
Tris, pH adjusted to 8.8 with HCl 
 
Table 6: Buffers for preparation of chemical competent E. coli cells 
Name Composition 
Tfb1 buffer 
30 mM potassium acetate, 100 mM RbCl, 100 mM 
CaCl2, 50 mM MnCl2, 15% (v/v) glycerol, pH 
adjusted to 5.8 with acetic acid 
Tfb2 buffer 
100 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15% 
(v/v) glycerol, pH adjusted to 6.5 with NaOH. 
 
Table 7: Buffers for isolation of mitochondria and subcellular fraction 
Name Composition 
Re-suspension buffer 100 mM Tris, 10 mM DTT 
Spheroplasting buffer 
1.2 M sorbitol, 20 mM potassium phosphate, pH 
7.2 
Homogenization buffer 
0.6 M sorbitol, 1 mM EDTA, 1 mM PMSF, 0.2% 
(w/v) fatty acid-free BSA, 10 mM Tris 7.4 pH 
adjusted with HCl 
SEM buffer 
250 mM sucrose, 1 mM EDTA, 10 mM MOPS, pH 
adjusted to 7.4 with KOH 
Percoll gradient buffer 
25% (v/v) Percoll, 250 mM sucrose, 10 mM 
MOPS/KOH pH 7.2, 1 mM EDTA, 2 mM PMSF 
 
Table 8: Buffer for sucrose gradient centrifugation 
Name Composition 
Swelling buffer 
20 mM HEPES/KOH, 2 mM EDTA, 2 mM PMSF 
pH 7.4 
High sucrose buffer 
2.2 M sucrose, 20 mM HEPES/KOH, 2 mM EDTA, 
2 mM PMSF, pH 7.4 
Low sucrose buffer 
0.45 M sucrose, 20 mM HEPES/KOH, 2 mM 
EDTA, 2 mM PMSF, pH 7.4 
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Sucrose gradient buffer 
2.5 M sucrose, 5 mM MOPS/KOH, 1 mM EDTA, 50 
mM KCL 
 
Table 9: Buffers for SDS-PAGE, Western blotting and immunodecoration 
Name Composition 
2x Lämmli buffer 
 
4% (w/v) SDS, 20% (v/v) glycerol, 0.02% (w/v) 
bromophenol blue, 5% (v/v) β-mercaptoethanol, 
160 mM Tris, pH adjusted to 6.8 with HCl 
SDS-running buffer 50 mM Tris, 1.61 M glycine, 1 g/l SDS 
Blotting buffer 
20 mM Tris, 150 mM glycine, 0.02% (w/v) SDS, 
20% (v/v) ethanol 
Ponceau staining solution 
8.5 ml of 72% TCA, 0.4 g Ponceau for 200 ml total 
volume 
TBS buffer 
10 mM Tris, 154 mM NaCl, pH adjusted to 7.5 with 
HCl 
TBST buffer TBS buffer, 0.05% (v/v) Tween20 
Blocking buffer 5% (w/v) powdered skim milk in TBS buffer 
ECL 
0.2 mM p-coumaric acid, 1.25 mM Luminol, 100 
mM Tris, pH adjusted to 8.5 with HCl.  30% H2O2 
were added before use in ratio 1:1000 to the ECL 
solution 
 
Table 10: Buffers for antibody stripping of membranes. 
Name Composition 
Stripping buffer 
86 mM Tris-HCl, pH adjusted to 6.8, 
2.9% (w/v) SDS, 1% (v/v) β-
mercaptoethanol 
 
Table 11: Buffers for colloidal Coomassie staining  
Name Composition 
Staining solution 
50 g aluminum sulfate hydrate, 100 ml 
ethanol, 0.2 g Coomassie Brilliant Blue 
G-250 (Serva Blue G), 23.5 ml 85% 
orthophosphoric acid in total volume of 
1000 ml 
Destaining solution 
100 ml ethanol, 23.5 ml 85% 
orthophosphoric acid in total volume of 
1000 ml 
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Table 12: Buffers for silver staining 
Name Composition 
Fixation solution 40% (v/v) ethanol, 10% (v/v) acetic acid 
Sensitizer solution 
30% (v/v) ethanol, 8 mM sodium thiosulfate, 500 
mM sodium acetate 
Silver solution 30 mM silver nitrate 
Developing solution 235 mM sodium carbonate, 0.02% (v/v) 
formaldehyde, 0.003% sodium thiosulfate 
Stopping solution 5% (v/v) acetic acid 
 
Table 13: Buffers for cell-free transcription and in vitro import of proteins into 
isolated mitochondria 
Name Composition 
Transcription buffer 
40 mM Tris-HCl pH 7.5, 10 mM NaCl, 6 mM MgCl2, 
2 mM spermidine 
F5-import buffer 
250 mM sucrose, 10 mM MOPS, 80 mM KCl, 5 
mM MgCl2×6H2O, 3% (w/v) fatty acid free BSA, pH 
adjusted to 7.2 with KOH 
SEM-K80 buffer SEM buffer with 80 mM KCl 
 
Table 14: Buffers for blue native PAGE 
Name Composition 
3X Gel buffer 
200 mM ɛ-Amino-n-caproic acid, 150 mM Bis-Tris, 
pH adjusted to 7.0 with HCL 
Solubilization buffer 
0.1 mM EDTA, 50 mM NaCl, 10% (v/v) glycerol, 1 
mM PMSF, 20 mM Tris, pH adjusted to 7.4 with 
HCL 
10× Cathode buffer A 
500 mM Tricine, 150 mM Bis-Tris, 0.2% (w/v) 
Coomassie G, pH 7.0  
10× Cathode buffer B 500 mM Tricine, 150 mM Bis-Tris, pH 7.0 
10× Anode buffer 500 mM Bis-Tris, pH adjusted to 7.0 with HCL 
10× loading buffer 
5% (w/v) Coomassie blue G, 500 mM ɛ-Amino-n-
caproic acid, 100 mM Bis-Tris, pH 7.0 
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Table 15: Buffers for pull-down assay 
Name Composition 
Pull-down buffer 
50 mM sodium phosphate, 10 mM MOPS, 20 % 
glycerol, pH adjusted to 7.5 
Solubilization buffer 
1% digitonin, 0.5% Triton X-100 or 0.5% DDM in 
pull-down buffer 
 
Table 16: Solutions for measurement of mitochondrial membrane potential  
Name Composition 
Fluorescence dye 2 µM 3,3’- DiSC3(5) in ethanol 
Buffer 
0.6 M sorbitol, 0.1% (w/v) BSA fatty acid-free, 0.5 
mM EDTA, and 20 mM KPI, pH 7.2 
Uncoupler 1 µM valinomycin in ethanol 
 
5.1.3 Enzymes  
Restriction enzymes and buffers used in this study were provided by New 
England Biolabs. Different DNA polymerase such as ExactRun, Taq, and Pfu DNA 
polymerase were provided by Fermentas. Enzymes for yeast cell wall and protein 
digestion, such as zymolyase (Seikagaku) and proteinase K (Roche) respectively, 
were used. SP6 was used for transcription of E. coli vector, which was provided by 
Progema. All the enzymes and buffers were used according to the manufacturer 
recommendations.  
 
5.1.4 Antibodies  
Antibodies mentioned below were used for immunodetection. Most of the 
antibodies were raised in rabbit, apart from HA (abcam), which was raised in rat. The 
antibodies were diluted in 5% skim milk in TBS buffer (mentioned in Table 9) in 
appropriate concentration, which is mentioned below in Table 17. Proteins were 
detected by secondary goat antibody anti-rabbit (BIORAD) or anti-rat (abcam) 
conjugated to horseradish peroxide (HRP). In this study, antibody against Coi1 was 
raised against a mixture of two peptides (peptide 1: a.a. 101-114 
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RGDKLGFLDRRRNE; peptide 2: a.a. 83-96 LVRKSKYE GSGLSA) injected in 
parallel into two rabbits and serum was obtained from Pineda. 
 
Table 17: Primary antibodies and their dilution factor 
Name Dilution 
Cellular localization of 
antigen 
α-Tom40 1:4000 MOM 
α-Tom20 1:1000 MOM 
α-Tom22 1:1000 MOM 
α-Tom70 1:1000 MOM 
α-Tob55 1:1000 MOM 
α-Fis1 1:1000 MOM 
α-Porin 1:4000 MOM 
α-Om45 1:1000 MOM 
α-Om14 1:4000 MOM 
α-Mim1 1:200 MOM 
α-Ugo1 1:1000 MOM 
α-Coi1 1:2000 MIM 
α-Dld1 1:1000 MIM 
α-Cor1 1:2000 MIM 
α-Cor2 1:2000 MIM 
α-Qcr6 1:1000 MIM 
α-Cox2 1:1000 MIM 
α-Cox4 1:1000 MIM 
α-Cox17 1:1000 MIM 
α-Pic2 1:1000 MIM 
α-AAC 1:1000 MIM 
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α-Tim23 1:1000 MIM 
α-Oxa1 1:1000 MIM 
α-Mic60 1:1000 MIM 
α-Tim11 1:1000 MIM 
α-Cyb2 1:1000 MIM 
α-Mcr1 1:1000 MOM/IMS 
α-Mge1 1:500 Matrix 
α-Aco1 1:4000 Matrix 
α-Bmh1 1:1000 Cytosol 
α-Erv2 1:1000 ER membrane 
α-Ssc1 1:5000 Matrix 
α-HA 1:3000 HA-tag  
 
5.1.5 Yeast and E. coli strains 
Cloning and plasmid isolation were performed in E. coli strain XL10 gold. Yeast 
strains used in this study are mentioned below in Table 18. 
 
Table 18: Yeast strains used in this study 
Strains Genotype Reference 
W303a 
MATa; ade2-1; can1-100; his3-11; 
leu2 3_112; trp1Δ2; ura3-52; 
Euroscarf, Frankfurt a. M., 
Germany 
 
coi1Δ W303a; coi1::HIS3MX6 This study 
W303α 
MATα; ade2-1; can1-100; his3-11; 
leu2 3_112; trp1Δ2; ura3-52; 
Thesis of J. Dukanovic 
mic60Δ W303α; mic60::HIS3MX6 Thesis of J. Dukanovic  
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5.1.6 Oligonucleotides and constructs  
Table 19: Oligonucleotides used in this study  
Name Sequence (5’ to 3’) Remarks 
coi1Δ FW 
 
G ATA AAT ATA GTA ATA TTT CAT 
TCT TTG AGC CGT ACT AAG TAT 
ACA ATG CGT ACG CTG CAG GTC 
GAC 
 
Amplification of KanMX4 
or HISMX6 
cassette 
coi1Δ RV 
 
T ACA TAA TAC TGC ATT GAA AAA 
ATG GAT AGG TTG ATT AAA CGT 
GTG ATC GAT GAA TTC GAG CTC 
G 
Amplification of KanMX4 
or HISMX6 
cassette 
Coi1 no 
intron FW 
GGG GAA TTC ATG TCA AAT CCA 
TTT CAA AAT ATA GGT AAG AAT 
TTA CTA TAC ATT TCT GCA GC 
 
Generating Coi1 without 
the intron: first 26 
nucleotide (Exon1) + 
from nucleotide 221 till 
the end (exon2)  
 
Coi1 no 
intron RV 
GGG GAA TTC ATG TCA AAT CCA 
TTT CAA AAT ATA GGT AAG AAT 
TTA 
Amplification of COI1 
ORF. 5’ contains EcoRI 
restriction site 
Coi1 RV 
CCC GGA TCC TTA CTC GTT TCT 
CCT CCT ATC TAA AAA AC 
Amplification of COI1 
ORF. 3’ contains BamH1 
restriction site 
Coi1 HA RV 
CCC GGA TCC CCC TCG TTT CTC 
CTC CTA TCT AAA AAA C 
Amplification of COI1 
ORF. 3’ contains BamH1 
restriction site and 
encoding for HA C-
terminal tag 
2-9Δ Coi1 
FW 
 
GGG GAA TTC ATG AAG AAT TTA 
CTA TAC ATT TCT GCA GCC 
Amplification of COI1 
ORF. 5’ 10-114 amino 
acids contains EcoRI 
restriction site 
1-30Δ Coi1 
FW 
 
GGG GAA TTC ATG AAA GCT AGA 
AGA GAT GCT AAA TTT ATA C 
 
Amplification of COI1 
ORF. 5’ 31-114 amino 
acids contains EcoRI 
restriction site 
Coi1 4x 
methionine 
RV 
CCC GGA TCC TTA CAT CAT CAT 
CAT CTC GTT TCT CCT CCT ATC 
TAA AAA AC 
 
Amplification of COI1 
ORF. 3’ contains BamH1 
restriction site and 
encoding for 4 
methionine 
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Coi1 FW Cys 
77-Ser 
 
GAC AAC ATT GAT TCT TCT GAG 
GAC C 
 
Amplification of COI1 
ORF. 3’ contains Ser at 
77 aa position instead of 
Cys 
Coi1 RV 
Cys77-Ser 
 
GGT CCT CAG A AGA ATC AAT 
GTT GTC 
 
Amplification of COI1 
ORF. 5’ contains Ser at 
77 aa position instead of 
Cys 
Coi1 Fw His 
81-Ala 
 
GCT CTG AGG ACG CTC AAT TAG 
TAA G 
 
Amplification of COI1 
ORF. 3’ contains Ala at 
81 aa position instead of 
His 
Coi1 Rv 
His81-Ala 
 
CTT ACT AAT TGA GCG TCC TCA 
GAG C 
 
Amplification of COI1 
ORF. 3’ contains Ala at 
81 aa position instead of 
His 
Coi1 Fw 
Cys77-Ser & 
His 81-Ala 
 
GAT TCT TCT GAG GAC GCT CAA 
TTA GTA AG 
 
Amplification of COI1 
ORF. 3’ contains Ser at 
77 aa & Ala at 81 aa  
Coi1 RV 
Cys77-Ser & 
His 81-Ala 
 
CTT ACT AAT TGA GCG TCC TCA 
GAA GAA TC 
Amplification of COI1 
ORF. 5’ contains Ser at 
77 aa & Ala at 81 aa 
Coi1 RV 85-
114 aa coi1Δ 
AAG GGG GAT CCT TAT ACT AAT 
TGA TGG TCC TCA GAG CAA TC 
 
Amplification of COI1 
ORF. 5’ 1-84 amino acids 
contains EcoRI restriction 
site 
Coi1 RV 88-
114 aa coi1Δ 
AAG GGG GAT CCT TAA CTC TTT 
CTT ACT AAT TGA TGG TCC TC 
Amplification of COI1 
ORF. 5’ 1-87 amino acids 
contains EcoRI restriction 
site 
Coi1 RV 99-
114 aa coi1Δ 
AAG GGG GAT CCT TAT GTT ACA 
GCA CTA AGC CCG CTA 
Amplification of COI1 
ORF. 5’ 1-98 amino acids 
contains EcoRI restriction 
site 
Coi1 RV 103-
114 aa coi1Δ 
AAG GGG GAT CCT TAA CCT CTT 
TTT CTT GTT ACA GCA CTA AG 
Amplification of COI1 
ORF. 5’ 1-102 amino 
acids contains EcoRI 
restriction site 
Coi1 RV 109-
114 aa coi1Δ 
AAG GGG GAT CCT TAA CCT AAT 
TTG TCA CCT CTT TTT CTT GTT 
AC 
Amplification of COI1 
ORF. 5’ 1-108 amino 
acids contains EcoRI 
restriction site 
 
31 
 
Table 20: List of plasmids used in this study  
Plasmids Promoter Marker(s) Reference 
pYX142 TPI Leu, Amp Laboratory stock 
pYX142-Coi1 TPI Leu, Amp This study 
pYX142-Coi1 C-ter HA TPI Leu, Amp This study 
pYX142-Coi1 2-9Δ TPI Leu, Amp This study 
pYX142-Coi1 1-30Δ TPI Leu, Amp This study 
pYX142-Coi1 Cys77Ser TPI Leu, Amp This study 
pYX142-Coi1 His81Ala TPI Leu, Amp This study 
pYX142-Coi1 85-114Δ TPI Leu, Amp This study 
pYX142-Coi1 88-114Δ TPI Leu, Amp This study 
pYX142-Coi1 99-114Δ TPI Leu, Amp This study 
pYX142-Coi1 103-114Δ TPI Leu, Amp This study 
pYX142-Coi1 109-114Δ TPI Leu, Amp This study 
pGEM4  SP6 Amp Promega 
pGEM4-AAC SP6 Amp 
(Sambrook J., 
1989) 
pGEM4-Oxa1 SP6 Amp 
(Gartner et al., 
1995)  
pGEM4-pSU9-DHFR SP6 Amp 
(Rapaport et al., 
1997) 
pGEM4-Porin SP6 Amp (Mayer et al., 1993) 
pGEM4-Tom40  SP6 Amp 
(Paschen et al., 
2003) 
pGEM4-F1β SP6 Amp 
(Rapaport et al., 
1997) 
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 Methods 5.2
5.2.1 Methods in molecular biology  
5.2.1.1 Polymerase chain reaction 
Polymerase chain reaction (PCR) is a method used to amplify a specific DNA 
template (Saiki et al., 1988). As a template for PCR, genomic and plasmid DNA were 
used. A standard PCR reaction contains in total 50 or 100 µl with 100 ng DNA 
template, 2 µl of 10 mM dNTPs, 1x PCR buffer, 1-2 U of Taq, pfu or EXACTRUN 
DNA polymerase, and H20. Buffers used in PCR are mentioned above in Table 5.  
PCR was performed in a thermocycler (Biometra) according to the two-step program 
mentioned below in Table 21.  
Table 21: General PCR program used in this study  
Step Temperature Time and cycles 
1 95 °C 5’ 
2 95 °C 1’ 
3 55 °C 1’ 
4 75 °C 1’ 30’’              Step #2 X 5 
5 95 ° C 1’ 
6 65 °C 1’ 
7 75 °C 1’30’’              Step #5 X 25 
8 75 °C 10’ 
9 4 °C Hold 
 
5.2.1.2 Agarose gel electrophoresis 
DNA fragments of different molecular masses were separated by agarose gel 
electrophoresis. They were separated on 0.5 - 2% (w/v) gels prepared in TAE buffer, 
containing 3% midori green or 2% gel red (Biotium). DNA samples were mixed with 
10x loading dye prior to loading onto the gel and electrophoresis was performed in 
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TAE buffer. To estimate the size of the DNA fragments, 1 kb DNA ladder (Fermentas, 
Gene RulerTM) was loaded in parallel. The bands were visualized by UV-light. 
 
5.2.1.3 DNA extraction from agarose gel  
DNA fragments of interest were extracted from the agarose gel on UV-light table. 
The purification was performed with Fast geneTM extraction kit (NIPPON Genetics) as 
mentioned in the user manual. 
 
5.2.1.4 Restriction digestion of DNA 
Endonucleases enzymes were used for restriction digestion of DNA. The 
restriction setup for PCR cloning or sub-cloning was done with 1-2 µg of DNA and 
incubation at 37°C for 2h. Inactivation of the enzymes was performed as stated in the 
user manual. 
 
5.2.1.5 Dephosphorylation of DNA fragments  
After restriction digestion of the vector, dephosphorylation was performed with 
shrimp alkaline phosphate (SAP) at 37°C to avoid re-ligation of the vector. SAP was 
heat inactivated at 65°C for 20 min before gel extraction of the linearized vector.  
 
5.2.1.6 Ligation with T4 DNA ligase 
Linearized vector and insert were purified with peqGOLD extraction kit (VWR). 
Ligation reaction was prepared in 20 µl  final reaction volume containing different ratio 
of vector to insert (1:3 or 1:6) with 3 µl of PEG 4000, 1 µl of ATP, 1X T4 ligation buffer 
and 1.5 µl of T4 ligase. Ligation sample were incubated overnight at 4°C in a water 
bath gradient and transformed into XL10 gold E. coli cells. 
 
5.2.1.7 Preparation of chemical competent E. coli cells  
XL10-gold E. coli strain was inoculated for overnight culture at 37°C in LB- 
chloramphenicol medium. The cells were diluted in 400 ml of fresh LB medium to an 
OD600=0.1 and grown to OD600=0.5. The cells were harvested by centrifugation 
(3000g, 5 min, 4°C) in pre-cooled tubes and the cell pellet was re-suspended in 160 
ml of pre-cooled TfbI buffer (Table 6) and incubated on ice for 15 min. The cell 
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suspension was harvested by centrifugation (4000 g, 10 min, 4°C), the pellet was re-
suspended in 16 ml pre-cooled TfbII buffer (Table 6) and incubated for 15 min on ice. 
Aliquots (100 µl) of the competent cells were snap-frozen in liquid nitrogen and 
stored at -80°C.  
 
5.2.1.8 Transformation of E. coli cells 
The plasmid containing gene of interest was transformed into XL10-gold 
competent cells. The plasmid or ligation mix was added to 100 μl of competent cells 
and incubated for 30 min on ice. Cells were subjected initially to a heat shock at 42°C 
for 45 sec and then a cold shock on ice for 2 min. Then, LB medium was added to 
the cells and incubated at 37°C for 30 min. Next, the cells were harvested by 
centrifugation (5000g, 5 min, RT) and re-suspended in 100 µl fresh LB medium. The 
re-suspended cells were plated on LB-Amp agar plates and incubated overnight at 
37°C.  
 
5.2.1.9 Plasmid isolation from E. coli strain in smaller scale (Miniprep) 
Small scale plasmid isolation from E. coli cells was done by using alkaline lysis 
method (Birnboim and Doly, 1979). After transformation, E. coli single colonies were 
picked and grown in 3 ml LB ampicillin medium for 16-18 h at 37°C. 2 ml of cultures 
were harvested by centrifugation (5000g, 5 min, RT) and re-suspended in 300 μl E1 
buffer. The cells were lysed in 300 μl E2 buffer by inverting gently 5 times and were 
incubated for 5 min at room temperature. Genomic DNA was precipitated by addition 
of 300 μl E3 buffer, inverting the tube again 5 times, and then by centrifugation step 
(15000g, 15 min, 2°C). Iso-propanol (96%) was then added to the supernatant in 
order to precipitate the plasmid, and the solution was centrifuged (15000g, 15 min, 
2°C). The pellet was washed with 70% ethanol and centrifuged again (15000g, 15 
min, 2°C). The pellet was re-suspended in 30 μl of H20 or directly into restriction 
digestion mix.  
 
5.2.1.10 Large scale plasmid DNA preparation (Midiprep)  
E. coli cells were shaken overnight in 50 or 100 ml culture at 37 °C. Isolation of 
plasmid-DNA was done by using PureYield Plasmid Midiprep System (Promega) as 
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mentioned in the user manual. DNA concentration was determined by photometer 
and the solution was stored at -20 °C. 
 
5.2.2 Methods in yeast genetics  
5.2.2.1 Cultivation of S. cerevisiae  
Yeast cells were grown in complete (YP medium) or synthetic medium (S 
medium) with fermentable (glucose or galactose) or non-fermentable (glycerol or 
lactate) carbon source according to published protocol (Sambrook J., 1989). Some 
auxotrophic markers were eliminated when strains were grown on synthetic selective 
medium (without leucine and histidine). In this study, all strains were grown in liquid 
medium at 30°C with constant shaking at 120 rpm. The cells were also grown on 
plates containing solid media at different temperature (15°C, 24°C, 30°C, and 37°C). 
The cells were stored for longer time periods in 15% glycerol solution in -80°C 
freezer, and on plates for short term at 4°C.  
 
5.2.2.2 Yeast transformation with the lithium acetate method 
Yeast cells were transformed by the lithium acetate method as previously 
described (Gietz et al., 1995). Cells were harvested by centrifugation (5000g, 5 min, 
RT) from freshly growing cells from liquid medium or small amount of cells from a 
plate. The cell pellet was re-suspended in 1 ml of 100 mM lithium-acetate and 
incubated for 5 min at 30°C with constant shaking at 500 rpm. The cells were 
collected again by centrifugation (5000g, 5 min, RT) and re-suspended in 240 μl of 
50% (w/v) polyethylene glycol 3350, 55 μl H2O, 36 μl 1 M lithium-acetate, 10 μl 
salmon sperm DNA (5 mg/ml) and 5 μl plasmid DNA or PCR product (100- 600 
ng/μl). The cell suspension was mixed and incubated at 42°C for 30 min with shaking 
at 800 rpm. The cells were centrifuged (5000g, 5 min, RT) and streaked on a plate 
with appropriate selective medium. The plates were incubated at 30°C for 2-4 days 
until single colonies appeared.  
 
5.2.2.3 Gene targeting in yeast by homologous recombination method  
Knockout of specific genes was obtained by the homologous recombination 
technique with the pFA6a-HIS3MX6 plasmid (Wach et al., 1997). For COI1 
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(YDR381C-A) deletion, the ORF was replaced in W303a background by the 
HIS3MX6 cassette with a PCR product obtained by using the specific primers 
mentioned in Table 19. The deletion cells were selected on SD plates lacking 
histidine at 30°C, and the genotype was confirmed by colony PCR with specific 
primers mentioned in Table 19. 
 
5.2.2.4 Site-directed mutagenesis  
COI1 was mutated with single or double point mutations by using ExtactRUN 
DNA polymerase. The primers were designed with 10-15 bp upstream and 
downstream of the mutated codon and are indicated in Table 19. The efficiency of 
the PCR was monitored on 1-2% agarose gel, and the PCR product was treated at 
37°C for 1 h with 1 µl of Dpn1. The samples were heat inactivated for 20 min at 80°C, 
and 5-10 µl of the PCR product was transformed into E. coli cells. 
 
5.2.3 Cell biology methods  
5.2.3.1 Drop dilution assay  
For drop dilution assay, cells were grown overnight at 30°C in 20 ml of synthetic 
or complete medium. On the next day, the cells were diluted to OD600 of 0.1 or 0.2 
and grown again until cells reached an OD600 of 1.0. Cells were then harvested by 
centrifugation (3000g, 3 min, RT) and washed with 1 ml sterile water. The cell pellet 
was re-suspended with sterile H2O to an OD600 of 2.0, and 5 µl of serial dilutions of 
fivefold increments were spotted on solid media. The plates were incubated at 
different temperatures (15°C, 24°C, 30°C and 37°C) for 2-3 days. 
 
5.2.3.2 Isolation of yeast crude mitochondria  
Yeast cells were inoculated into 50 ml culture and incubated overnight at 30°C. 
On the next day, the culture was diluted into 200 ml of fresh medium to an OD600 of 
0.1- 0.2. Once the cells reached the logarithmic phase (OD600 of 0.8- 1.0), they were 
harvested (3000 g, 5 min, RT) and re-suspended in 2.4 ml of SEM buffer 
supplemented with 2 mM PMSF. The cell suspension was distributed in four 
Eppendorf tubes containing each 600 mg of glass beads. Cells were broken open by 
vortexing five times for 1 min with interval of 1 min on ice in between. Cell debris and 
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beads were sedimented by centrifugation (1000g, 3 min, 2°C), and the supernatant 
corresponding to the whole cell lysate (WCL) was collected in a fresh tube. Protein 
concentration of the WCL was measured with the Bradford method, and the WCL 
fraction was centrifuged (20000g, 15 min, 2°C) to isolate crude mitochondria at the 
pellet, whereas the supernatant represents the cytosol fraction. Aliquots of 200 µl of 
WCL and cytosol fractions were precipitated by chloroform-methanol method. The 
samples representing the crude mitochondria, WCL and cytosol, were re-suspended 
in 2x Lämmli buffer, cooked for 5 min at 95°C and stored at -20°C until they were 
analyzed on the SDS-PAGE. 
 
5.2.3.3 Isolation of mitochondria from yeast cells 
Isolation of S. cerevisiae mitochondria was performed as previously described 
(Daum et al., 1982) with minor modification. The cells were grown at 30°C in total 
volume of 2-10 l of suitable medium to an OD600 of 0.8-1.5 and harvested by 
centrifugation (3000g, 5 min, 20°C). The cell pellet was washed with 200 ml H2O and 
cells were centrifuged again (3000g, 5 min, 20°C), the pellet was weighted and then 
re-suspended in suspension buffer (Table 7) to a ratio of 2 ml per g cells. Cell 
suspension was incubated at 30°C for 10 min with a constant shaking, and the cells 
were harvested by centrifugation (5 min, 3000g, 20°C). The cells were re-suspended 
to a ratio of 2 ml/g of cells in spheroblasting buffer and centrifuged again (5 min, 
3000g, 20°C). Next, the cell wall was digested by re-suspending the cells with 
spheroblasting buffer containing 4.5 mg zymolyase (per g of wet cells weight) and 
was incubated at 30°C for 60 min. The spheroblasting efficiency was monitored 
photometrically by adding 20 μl of the spheroblasting solution to 1 ml of either H2O or 
1.2 M sorbitol. The OD600 in water should be eight to ten-fold less compared to that in 
1.2 M sorbitol, upon complete spheroblasting of the cells. The cells were re-isolated 
by centrifugation (2000g, 5 min, 2°C) and re-suspended in 13 ml/g cells in 
homogenization buffer. Cells were homogenized by 10 strokes in tight fitting glass 
homogenisator on ice, and homogenized cells were centrifuged (2000g, 5 min, 2°C) 
twice to get rid of cell debris.  
Mitochondria were isolated from clarified supernatant with higher centrifugation 
step (18000g, 15 min, 2°C). The mitochondrial pellet was further centrifuged twice at 
lower centrifugation (2000g, 5 min, 2°C), and at the final step, mitochondria were 
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isolated again at higher centrifugation (18000g, 15 min, 2°C). The mitochondrial 
pellet was re-suspended in 1 ml SEM buffer supplemented with 2 mM PMSF. 
Aliquots of appropriate concentration were snap-frozen in liquid nitrogen and stored 
at -80°C.  
 
5.2.3.4 Subcellular fractionation of yeast cells 
Isolation of mitochondria was performed as mentioned above (5.2.3.3). After the 
homogenization step, 2 ml of sample, which corresponds to whole cell lysate (WCL), 
was collected. After the first centrifugation step to obtain mitochondria (18000g, 15 
min, 2°C) the supernatant was collected, which corresponds to post-mitochondrial 
supernatant (cytosolic and light ER fraction). To isolate highly pure mitochondria, the 
mitochondria fraction was loaded onto 17.5 ml Percoll gradient solution (25% Percoll) 
(Table 7) and separated by ultracentrifugation (80000g, 45 min, 2°C). The purified 
mitochondria migrate in the lower half of the gradient, which was transferred with the 
glass tip into a fresh tube, containing 30 ml of SEM buffer. Pure mitochondria were 
isolated by centrifugation (15000g, 15 min, 2°C), and the pellet was re-suspended in 
500 μl SEM buffer. Aliquots (50 μl) were flashed frozen in liquid nitrogen and stored 
at -80°C until further use.  
Microsomes were isolated from post-mitochondrial supernatant with an initial 
clarifying spin (15000g, 15 min, 2°C). The supernatant was centrifuged (130000g, 1 
h, 2°C), and the microsomes were re-suspended in 500 μl SEM buffer and subjected 
to another clearing spin (8000g, 10 min, 2°C). Aliquots (50 μl) were stored at -80°C 
until further use. 
 
5.2.3.5 Separation of mitochondrial outer and inner membrane proteins by 
sucrose gradient 
Isolated mitochondria (3 mg), obtained from cells grown on lac medium were re-
suspended in 1 ml SEM supplemented with 2 mM PMSF, and the organelles were re-
isolated by centrifugation (12000g, 5 min, 2°C). The mitochondria were swollen at 
4°C for 1 h in 10 ml of swelling buffer in a 15 ml falcon tube placed on an overhead 
shaker. Next, the density of the sample was adjusted by adding high sucrose buffer 
to a final concentration 0.4 M. The swollen mitochondria were ruptured by sonication 
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(8x 3 sec; 2 min intervals, on ice) by using mini sonication tip (70% duty cycle, output 
6) immersed 2 cm into the sample solution. The mitochondrial vesicles were 
harvested by ultracentrifugation in 60Ti tubes (Beckmann) (20000g, 2h, 2°C), and the 
pellet was thoroughly re-suspended in 400 µl of low sucrose buffer. The pellet was 
sonified at 4°C in a water bath for 5-10 min and centrifuged (35000g, 15 min, 2°C) to 
get clarified vesicles. In the meantime, the sucrose gradient was prepared in SW60 
tubes (Beckmann). The pipetting scheme of the gradient is mentioned in the Table 22 
below. To obtain the outer and inner membrane proteins, the supernatant was loaded 
on the sucrose gradient and centrifuged (230000g, 16 h, 2°C) in SW60 rotor 
(Beckmann). The gradient was carefully harvested from top to bottom in aliquots of 
90 µl that were further mixed with 4x Lämmli and analyzed by SDS-PAGE.  
Table 22: Pipetting scheme for sucrose gradient  
Molarity 
(M) 
Gradient buffer  
(in µl) 
Sucrose gradient buffer  
(in µl) 
0.9 959 541 
1.0 900 600 
1.1 840 660 
1.2 779 721 
1.3 720 780 
1.4 660 840 
 
5.2.3.6 Fluorescence microscopy of yeast cells  
Yeast cells were transformed with pVT100U-mtGFP vector (Westermann and 
Neupert, 2000), harboring mitochondrial targeted green fluorescent protein. Yeast 
cells containing the vector were grown to logarithmic phase, and 5 µl of culture were 
used to examine the mitochondrial morphology under fluorescence microscope 
(Zeiss Axioscope) with 100x magnification.  
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5.2.4 Biochemical methods 
5.2.4.1 Determination of protein concentration 
To determine protein concentration, the Bradford method was applied (Bradford, 
1976). The protein solution (10 μl) was diluted in 1 ml of Roti-Quant Bradford solution 
(1:5 dilution in SEM buffer) and incubated at room temperature for 5 min in darkness. 
To determine standard curve, 2-10 μg of BSA from 1 mg/ml stock were used.  
The absorbance of the samples was measured at 595 nm, and protein concentration 
was estimated according to the calibration plot.  
 
5.2.4.2 Protein precipitation by trichloroacetic acid (TCA)  
Aqueous protein solution was precipitated by adding 72% TCA to a final 
concentration of 12%. The samples were vortexed and then incubated on ice for 30 
min and centrifuged (30000g, 20 min, 2°C). A volume of 500 μl of 90 % acetone was 
used to wash the pellet, and subsequently, the pellet was dried at 50°C for 10 min. 
The pellet was re-suspended in 2x Lämmli buffer and incubated at 95°C for 5 min.  
 
5.2.4.3 Protein precipitation by chloroform-methanol  
To precipitate higher amounts of protein, chloroform-methanol precipitation was 
performed (Wessel and Flugge, 1984). Four volumes of methanol, three volumes of 
chloroform, and three volumes of water were added to the samples and vortexed 
thoroughly. The samples were separated by centrifugation (16000g, 1 min, RT) into 
two phases. The upper phase was carefully removed and three volumes of methanol 
were added to the lower phase. After vortexing, the samples were centrifuged 
(16000g, 1 min, RT) and the pellet was air dried at 50°C. Then, the pellet was re-
suspended with 2x Lämmli buffer and incubated at 95°C for 5 min.  
 
5.2.4.4 Carbonate extraction 
Mitochondria were subjected to alkaline extraction as published before (Fujiki et 
al., 1982). Isolated mitochondria (50 μg) were re-suspended in 50 μl of 20 mM 
HEPES/KOH pH 7.5, and then 50 μl of freshly prepared pre-cooled 200 mM sodium 
carbonate solution was added. The samples were incubated on ice for 30 min prior to 
separation of soluble and membrane proteins by ultracentrifugation (120000g, 1 h, 
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2°C). The supernatant containing soluble fraction was precipitated by the TCA 
method, whereas the pellets were re-suspended directly in 50 μl 2x Lämmli and 
incubated for 5 min at 95°C.  
 
5.2.4.5 Proteinase K treatment of mitochondria  
Mitochondria (50 µg) were re-suspended in 100 µl SEM buffer, and the solution 
was supplemented with Proteinase K (50 and 200 µg/ml). The samples were 
incubated on ice for 30 min. As a control, mitochondria were treated on ice with 0.2% 
Triton X-100 in SEM buffer for 20 min and subjected to PK treatment as described 
above. To stop the reaction, 2 µl of 200 mM PMSF were added to all samples. 
Mitochondria were re-isolated (18,000g, 20 min, 2°C), while proteins from the Tx-100 
containing samples were precipitated by TCA. The pellet was re-suspended in 50 µl 
of 2x Lämmli buffer, incubated for 5 min at 95°C and further analyzed by SDS-PAGE. 
 
5.2.4.6 SDS-PAGE  
Protein samples were analyzed on denatured condition in 10-15 % SDS-PAGE gels. 
The SDS gel was casted between two glass plates with 1 mm spacing in between, 
and to avoid leakage, the bottom gel was separately prepared. The composition of 
bottom, running, and stacking gel are described in Table 23, and buffer composition 
in Table 9 above. The protein samples were prepared in 2x Lämmli with 
concentration of 2 µg/µl (15 µg- 100 µg) and denatured at 95°C for 5 min before 
being subjected to SDS-PAGE. Electrophoresis was performed at 20 mA per gel, for 
approximately 3 h until the dye front reached the bottom gel. A protein ladder (PAGE 
RulerTM, Fermentas) was used as a molecular weight markers. 
 
5.2.4.7 Western blotting  
Proteins from SDS-PAGE were transferred onto the nitrocellulose membrane 
(Whatman) by semi-dry blotting technique as described previously (Kyhse-Andersen, 
1984; Towbin et al., 1979). Three filter papers (3 mm) were soaked in blotting buffer 
(Table 9) and placed on the blotting apparatus followed by the nitrocellulose 
membrane. The SDS gel was placed on the membrane, and additional three filter 
papers were placed on top of the gel. Air bubbles were removed by rolling a glass 
pipette over the assembled blot. The proteins were transferred for 1.5 h at 220 mA. 
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The efficiency of the protein transfer was monitored by incubating the membrane in 
Ponceau staining solution (Table 9) for 1-2 min, followed by several washes.  
 
Table 23: Composition of gels used for SDS-PAGE  
Components 
Bottom gel Running gel Stacking 
gel 
15% 10% 12.5% 15% 
40% aa/bis-aa 
(29:1) 
3.75 ml 3.13 ml 3.91 ml 4.69 ml 563 µl 
1M Tris pH 8.8 3.75 ml 4.69 ml 4.69 ml 4.69 ml - 
1M Tris pH 6.8 - - - - 625 µl 
water 2.39 ml 4.55 ml 3.77 ml 2.99 ml 3.76 ml 
10% APS 100 µl 125 µl 125 µl 125 µl 50 µl 
TEMED 8 µl 10 µl 10 µl 10 µl 4 µl 
Total volume 10 ml 12.5 ml 12.5 ml 12.5 ml 5 ml 
 
5.2.4.8 Immunodetection of proteins  
To avoid unspecific binding of antibodies, membranes with blotted proteins were 
incubated at room temperature with 5% skim-milk in TBS buffer for 1 h. Membranes 
were briefly washed with TBS before incubating them with primary antibodies at 4°C 
overnight or at room temperature for 1 h. The membranes were then washed twice 
with TBS and once with TBST before their incubation at room temperature with 
secondary antibodies (1:10000) in 5% skim-milk for 1 h. To detect the specific 
proteins, the secondary antibody was conjugated to HRP. A chemiluminescence 
signal was obtained upon adding ECL and H202. This signal was detected by X-ray 
films (Super RX, Fuji) and these were developed by an X-ray film developing 
machine (SRX-101A Konica Minolta). 
 
5.2.4.9 Colloidal Coomassie staining  
After gel electrophoresis, proteins were visualized by Coomassie staining. The 
gel was shortly washed with water before incubating in staining solution for either 1-2 
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h or overnight. De-staining solution was then added to remove excess of Coomassie 
staining, and the bands of interest were cut out for protein analysis by mass 
spectrometry. 
 
5.2.4.10 Blue native PAGE (BN-PAGE) 
Membrane proteins were analyzed under native conditions by applying blue native 
gel electrophoresis (BN-PAGE) as mentioned previously (Schagger and von Jagow, 
1991). Isolated mitochondria (50 - 100 µg protein) were re-isolated in SEM buffer by 
centrifugation (12000g, 10 min, 2°C), and the pellet was lysed in sample buffer 
containing 1% digitonin (protein: detergent ratio of 1:10 (w/w)), or 0.5% solution of 
either Triton X-100, or DDM (resulting in protein: detergent ratio of 1:3). The 
solubilized samples were incubated on ice for 20-30 min and centrifuged (30000g, 20 
min, 2°C) to get rid of non-solubilized material in the pellet. The solubilized 
mitochondrial proteins in the supernatant were mixed with 5 µl of 10x loading 
buffer and analyzed on 3-13% acrylamide gradient gel. BN-PAGE (Table 24) was 
performed at 4°C as described previously (Schägger, 2002). Whereas, the first part 
of the gel was run at 150 V and 15 mA for 2 h in cathode B buffer. Next, the buffer 
was switched to cathode A buffer, and the gel was ran further at 50 V, 15 mA 
overnight. The native gel was either blotted to PVDF membranes or stained with 
Coomassie. 
  
Table 24: Composition of gels used for BN-PAGE  
Components 
Bottom 
gel 
Stacking 
gel 
3.5% 4 % 6% 8% 10% 13% 
48%AA/1.5% 
Bis-AA 
5 ml 0.417 ml 
0.44 
ml 
0.5 
ml 
0.75 
ml 
1 ml 
1.25 
ml 
1.625 
ml 
3X gel buffer 3.3 ml 1.67 ml 2 ml 2 ml 2 ml 2 ml 2 ml 2 ml 
water 1.7 ml 2.88 ml 3.4 ml 
3.47 
ml 
3.22 
ml 
1 ml 
0.75 
ml 
- 
60% (V/V) 
glycerol 
- - - - - 2 ml 2 ml 
2.355 
ml 
10% APS 50 µl 30 µl 50 µl 30 µl 25 µl 20 µl 20 µl 20 µl 
TEMED 25 µl 3 µl 3 µl 3 µl 2 µl 2 µl 2 µl 2 µl 
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5.2.4.11 In vitro transcription and translation of radiolabeled precursor 
proteins 
Transcription was done in the presence of SP6-polymerase as mentioned 
previously (Melton et al., 1984; Trochimchuk et al., 2003). In vitro transcription was 
performed in a mixture of total volume of 50 µl containing: 10 μl SP6-buffer, 5 μl 10 
mM DTT, 2 μl (80U) RNAse inhibitor (Promega), 10 μl 2.5 mM rNTP-mix (GE 
Healthcare), 2.6 μl of 0.8 mM methyl G(5´)ppp(5´)G cap (Amersham), 5 μg plasmid 
DNA, and 1.5 μl (75 U) SP6 Polymerase. The Transcription reaction was performed 
at 37°C for 1 h, and the resulting mRNA was precipitated by adding 5 μl of 10 M LiCl 
and 150 μl ethanol p.A. for 4-5 h at -20°C. The mRNA was further isolated by 
centrifugation (37000g, 20 min, 2°C) and washed with 500 μl ice-cold 70% ethanol. 
The dry mRNA was re-suspended in 37 μl H2O with 2 μl RNAse inhibitor, and 
aliquots of suitable volumes were stored in -80°C. 
Translation of mRNA was performed in a mixture containing: 50 μl rabbit 
reticulocyte lysate (Promega), 12.5 μl mRNA, 1.75 μl amino-acid without methionine, 
3.5 μl Mg-acetate, 0.5 μl RNAse inhibitor, and 6 μl 35S-methionine (10 mCi/ml). The 
reaction was incubated for 1 h at 30°C, and then 6 μl of 58 mM methionine and 12 μl 
of 1.5 M sucrose were added to the reaction. Precursor proteins were obtained at the 
supernatant of a centrifugation step (90000g, 50 min, 4°C, TL45).  
 
5.2.4.12 In vitro import of radiolabeled precursor proteins into mitochondria 
The import of precursor proteins were performed at 25°C in the presence of 
isolated mitochondria (50 µg) for the indicated time periods in import buffer. The 
import reaction was stopped by diluting the import mixture with SEM K80 buffer (Table 
13), and mitochondria were re-isolated (12,000g, 2 min, 4°C). In some experiments, 
the organelles were treated with PK as described in section 5.2.4.5 before re-
isolation. Mitochondrial pellets were re-suspended in 2x Lämmeli buffer and analyzed 
by SDS-PAGE. 
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5.2.4.13 Autoradiography and quantification of bands 
The radiolabeled proteins separated on the SDS-PAGE were transferred to 
nitrocellulose membrane and detected by X-ray film (Kodak Bio Max MM). The signal 
of radiolabeled proteins depends on number of methionine present in the protein. 
Therefore, the detection of a signal varied from 2 to 30 days. The bands were 
quantified by using AIDA image analyzer tool. 
 
5.2.4.14 Measurement of mitochondrial membrane potential  
The membrane potential across the inner membrane (Δψ) was measured by 
fluorescence quenching of the membrane potential sensitive dye DiSC3(5) (Sigma) 
by a modified published procedure (Gartner et al., 1995). DiSC3(5) dye (3 µl) was 
added at 25°C to a cuvette with 3 ml buffer. The fluorescence was monitored by 
fluorescence spectrometry (F-800, Jasco) with excitation at 622 nm and emission at 
670 nm, and the data was taken at 2 sec intervals. Once the fluorescence of the dye 
was stabilized, 50 µg of mitochondria in SEM buffer were added to the cuvette, and 
flurorescence was further measured until a stable signal was obtained. The 
complete dissipation of the membrane potential was achieved by adding 3 µl of 
valinomycin, and the increase in the fluorescence was monitored. For the 
assessment of the membrane potential, the difference between the fluorescence 
level before and after adding the valinomycin was estimated. 
 
5.2.4.15 Pull-down assay 
Isolated mitochondria (1 mg) were solubilized at 4°C for 30 min in 600 µl of lysis 
buffer containing 1% (w/v) digitonin, 0.5% (w/v) Triton X-100, or 0.5% (w/v) DDM. 
Anti-HA magnetic beads (Pierce TM ThermoFischer Scientific) were washed twice with 
lysis buffer and then equilibrated with the buffer at 4°C for 30 min. The solubilized 
organelles were subjected to a clarifying spin (30,000xg, 20 min, 4°C), and the 
supernatant was incubated at 4°C overnight with the equilibrated anti-HA beads. The 
unbound material was removed, and the beads were washed thoroughly with lysis 
buffer containing 0.1% Triton X-100, digitonin, or DDM. Bound proteins were eluted 
with 2x Lämmeli without reducing agent and analyzed by SDS-PAGE.  
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6 Results 
As part of my efforts to better understand the assembly of the cytochrome c 
oxidase complex, I decided to investigate the uncharacterized ORF YDR381C-A. 
This protein was found in the interactome of Cox4 of the inner membrane (Bottinger 
et al., 2013), but was previously also described in a high-throughput study to be 
included in the proteome of the MOM (Zahedi et al., 2006). The protein has a 
molecular mass of 12.7 kDa and lacks homologs in higher eukaryotes. According to 
in silico prediction, Ydr381C-A has a putative transmembrane segment in its N-
terminal region (a.a. 11-30) (Quick2D, http://toolkit.tuebingen.mgp.de) (Fig 6.1). I 
wanted to understand the biological role and the mechanism of action of this protein, 
and due to reasons described below, I re-named YDR381C-A to Cytochrome c 
Oxidase Interacting protein 1 (COI1).  
 
Figure 6.1 Schematic depiction of Coi1. Coi1 is predicted to have a single transmembrane 
segment (TMS) that includes a.a. residues 10-30. The putative TMS is indicated with a grey 
box. 
 
 Coi1 is an inner mitochondrial membrane protein  6.1
To better characterize Coi1, a specific antibody is an essential tool. I obtained 
several sera from the company Pineda and monitored by Western blotting the 
specificity of the antibodies.  
 
Figure 6.2 Serum raised in rabbit against Coi1. WT or coi1Δ cells were transformed with 
an empty plasmid or with a plasmid encoding C-terminally HA-tagged Coi1. Mitochondria 
were analyzed by SDS-PAGE and immunodecorated with antibody against Coi1. 
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The quality and specificity of coi1 antibody is demonstrated in Figure 6.2. It shows a 
signal at the expected size of the protein at ~15 kDa, the absence of a signal in a 
deletion strain, and a shift in the protein´s migration upon usage of HA-tagged 
version. This antibody was used in the experiments described in this thesis. 
To confirm the reported mitochondrial location of Coi1 at a single gene level, 
subcellular fractionation of wild type cells was performed. The obtained fractions 
were analyzed by immunoblotting with an antibody against Coi1. Similarly to the 
known mitochondrial protein Tom40, Coi1 was enriched in the mitochondrial fraction 
(Fig 6.3 lane 4). This observation confirms that Coi1 is a mitochondrial protein. Since 
the protein harbors a putative TMD, four different topologies of the protein with 
respect to the mitochondrial membranes can be considered (Fig. 6.4A). However, I 
wondered whether the protein is indeed inserted into a membrane. To address this 
issue, isolated organelles were subjected to alkaline extraction, where soluble and 
peripheral membrane proteins were separated from integral membrane proteins. 
Coi1 was present in the membrane fraction like known MOM proteins such as Tom20 
and Om45 (Fig 6.4B lanes 6 and 7). Thus Coi1 is a membrane-embedded protein. 
 
Figure 6.3 Coi1 is a mitochondrial protein. Coi1 is a mitochondrial protein. Whole-cell 
lysate (WCL) and fractions corresponding to cytosol (cyt), light microsomal fraction (ER) and 
mitochondria (mito) were analyzed by SDS-PAGE and immunodecorated with antibodies 
against Coi1, Bmh1 (cytosolic protein), Erv2 (ER protein), and Tom40 (mitochondrial 
protein). 
 
To address the topology of Coi1 and to discriminate among the aforementioned 
topological possibilities, proteinase K (PK) was added to isolated mitochondria. 
Proteins exposed to the cytosolic side such as Tom20 were cleaved by PK, whereas 
the signal of Coi1 was still detectable. On the other hand, Coi1 could not be detected 
in lysed mitochondria treated with PK, suggesting that Coi1 is protected from the 
action of PK in intact mitochondria (Fig 6.4B lanes 1-5). Thus, topology #1 as 
depicted in Figure 6.4A can be excluded. To further investigate the orientation of Coi1, 
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mitochondria were swollen in hypo-osmotic conditions to disrupt the outer membrane 
and subsequently were treated with PK. These conditions eliminated the signal of 
both Coi1 and the IMS protein Dld1. In contrast, the matrix protein Aco1 remained 
resistant under these conditions, demonstrating the intactness of inner membrane 
(Fig 6.4C lane 4). Considering that the antibody against Coi1 was raised against C-
terminal peptides, this outcome suggests that the C-terminus of Coi1 is facing 
towards IMS (options #2 or #3 in Fig 6.4A).  
 
Figure 6.4 Coi1 is membrane embedded and facing towards the IMS. (A) Schematic 
representation of the four theoretical possibilities for the membrane topology of Coi1. (B) 
Coi1 is membrane embedded and protected from external protease. Isolated mitochondria 
were subjected to externally added proteinase K (PK) in the presence or absence of the 
detergent Triton X-100 (lanes 1-5). Other samples were subjected to alkaline extraction 
(lanes 6-7 right). The pellet (P) and the supernatant (S) fractions were analyzed by SDS-
PAGE and immunoblotting. Om45, OM protein facing towards IMS; Tom20, OM protein 
exposed towards the cytosol; Mcr1, has two isoforms, a 34 kDa OM form and a 32 kDa IMS 
form; Aco1, soluble matrix protein. (C) Coi1 is exposed to the IMS. Isolated mitochondria 
were left untreated or were swollen before PK was added in the presence or absence of 
Triton X-100. Samples were analyzed by SDS-PAGE and immunodecoration with antibodies 
against the indicated proteins. Dld1, an IM protein facing the IMS. *, indicates degradation 
product. 
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To find out in which membrane Coi1 is embedded, mitochondrial OM and IM 
vesicles were obtained by hypo-osmotic swelling and sonication. The vesicles were 
separated by sucrose gradient centrifugation and the collected fractions were 
analyzed. Coi1 was predominately detected in heavier fractions very similar to the IM 
protein Cox2. In contrast, the OM protein Tom20 was mainly found in the lighter 
fractions (Fig 6.5). Taken together, these results suggest that Coi1 is embedded in 
the mitochondrial IM, facing towards the IMS (Fig 6.4A, topology #3).  
 
Figure 6.5 Coi1 is inner membrane protein. Isolated mitochondria were subjected to 
sonication followed by sucrose density gradient centrifugation. Fractions of the gradient were 
collected and analyzed by SDS-PAGE and immunodecorated with antibodies against the 
indicated proteins. Right panel: the intensities of the various bands were quantified and 
depicted. The sum of all intensities of each protein was set to 100%.  
 
  Loss of COI1 has a severe growth effect on yeast cells  6.2
To investigate the function of Coi1 in yeast cells, the chromosomal copy of COI1 
was deleted, and the growth of the deletion strain was analyzed. The coi1Δ strain 
showed a severe growth phenotype on both non-fermentable (YPG and SG-Leu) and 
fermentable (YPGal and SGal-Leu) carbon sources at all temperatures tested. (Fig 
6.6A). This growth phenotype is a direct result of the COI1 deletion as it could be 
complemented by overexpression of either native Coi1 or C-terminally HA-tagged 
Coi1 (Fig 6.6A).  These observations further verify that ectopically expressed Coi1 
and Coi1-HA are functional. Accordingly, Coi1-HA was found to be in the 
mitochondrial fraction upon subcellular fractionation (Fig 6.6B lane 4). Altogether, the 
loss of Coi1 results in a severe growth phenotype, and overexpression of the protein 
can rescue this growth phenotype. 
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Figure 6.6 Deletion of COI1 results in a severe growth phenotype. Wild type and coi1Δ 
cells were transformed with an empty plasmid, whereas the latter cells were transformed also 
with a plasmid encoding either Coi1 or Coi1-HA. (A) Cells were tested by drop dilution assay 
at the indicated temperatures on medium containing either the non-fermentable carbon 
source, glycerol (YPG and SG-Leu), or the fermentable carbon source, galactose (YPGal 
and SGal-Leu). (B) Coi1-HA is localized to mitochondria. Whole-cell lysate (WCL) and 
fractions corresponding to cytosol (cyt), light microsomal fractions (ER) and mitochondria 
(mito) from coi1Δ cells expressing Coi1-HA were analyzed by SDS-PAGE and 
immunodecoration with antibodies against HA (Coi1-HA), Tom40 (mitochondrial protein), 
Erv2 (ER protein), and Bmh1 (cytosolic protein). 
 
Next, I wondered whether overexpression of Coi1 might have a harmful effect on 
the cell growth. To this end, either native Coi1 or C-terminally HA-tagged Coi1 was 
overexpressed in wild type cells. The results of the drop dilution assay indicate that 
ectopically expressed Coi1 and Coi1-HA had no negative functional effect on wild 
type cells (Fig 6.7). Hence, Coi1 in higher amounts has no adverse effect on the 
yeast cells.  
52 
 
 
Figure 6.7 Overexpression of Coi1 has no negative effect on wild type cells. Wild type 
and coi1Δ cells were transformed with an empty plasmid or plasmid encoding either Coi1 or 
Coi1-HA. Cells were tested at 30°C or 37°C by drop dilution assay on rich medium containing 
either non-fermentable carbon source glycerol (YPG and SG-Leu) or the fermentable carbon 
source galactose (YPGal and SGal-Leu).  
 
 The transmembrane domain of Coi1 is crucial for its function  6.3
Coi1 has a single putative transmembrane segment of 20 amino acids towards its 
N-terminus region (a.a. 11-30). It also does not have a canonical presequence (Fig 
6.8A). To understand more about the importance of the N-terminal region, two N-
terminal truncated versions of Coi1 lacking either amino acids 2-9 (coi1-2-9Δ) or 2-30 
(coi1-2-30Δ) were generated (Fig 6.8A). To test whether the deleted amino acids 
play a role in targeting and localization of the protein, the mutated variants were 
ectopically expressed in coi1Δ cells and complementation assay was performed. The 
growth phenotype from deletion of COI1 was not rescued by coi1-2-30Δ, whereas 
coi1-2-9Δ showed only slightly reduced complementation capacity (Fig 6.8B). In 
agreement with the moderately reduced functionality, the steady state levels of coi1-
2-9Δ were somewhat reduced in both WCL and mitochondrial fraction in comparison 
to overexpressed full length Coi1. The coi1-2-30Δ variant was not detected at all, 
suggesting that loss of the putative TMS probably leads to rapid degradation of the 
truncated version (Fig 6.9A).  
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Figure 6.8 The transmembrane domain of Coi1 is required for its function. (A) 
Schematic illustration of full length and truncated forms of Coi1. (B) coi1Δ cells were 
transformed with an empty plasmid or with plasmid encoding Coi1 or its truncated variants. 
DDA was performed at the indicated temperatures on the specified medium. 
 
To test if coi1-2-9Δ is embedded in the membrane, alkaline extraction was 
performed to separate soluble and membrane proteins. Despite its reduced steady-
state levels, coi1-2-9Δ was inserted into the membrane similarly to full length Coi1 
and the MOM protein Tom40 (Fig 6.9B). These findings indicate that residues 2-9 of 
Coi1 have only a slight effect on the stability and function of the protein, whereas 
residues 11-30 appear to be crucial for stability of the protein and its correct 
mitochondrial targeting.  
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Figure 6.9 The transmembrane domain of Coi1 is crucial for the stability of the protein. 
(A) Crude mitochondria and whole cell lysate (WCL) were isolated from the indicated strains. 
Samples were analyzed by SDS-PAGE and immunodecoration with antibodies against Coi1, 
Cox2 (IM protein), and Tom20 (OM protein). (B) Isolated mitochondria were subjected to 
alkaline extraction. The pellet (P) and the supernatant (S) fractions were analyzed by SDS-
PAGE and immunodecorated with the antibodies against the indicated proteins.  
 
 Conserved residues of Coi1 have a functional role  6.4
Coi1 has homologs in many fungi and it contains several conserved, positively 
charged amino acids at its C-terminus (Fig 6.10). To understand the role of these 
amino acids, different C-terminal truncations of Coi1 were generated, and a 
complementation assay was performed. Truncated versions of Coi1 lacking amino 
acids 85-114 (coi1-85-114Δ), 88-114 (coi1-88-114Δ), 99-114 (coi1-99-114Δ), 103-
114 (coi1-103-114Δ), or 109-114 (coi1-109-114Δ) were constructed (Fig 6.10). Next, 
these variants were ectopically expressed in coi1Δ cells. The growth phenotype of 
coi1Δ cells was not rescued by coi1-85-114Δ, coi1-88-114Δ, and coi1-99-114Δ, 
whereas coi1-103-114Δ and coi1-109-114Δ showed a partial rescue capacity (Fig 
6.11A). As a positive control, full length Coi1 was able to rescue the coi1Δ phenotype 
(Fig 6.11A). Obviously, lack of complementation capacity can result from low 
expression level of these variants. To test the steady state levels of the various Coi1 
forms, mitochondria were isolated and the levels of the truncated Coi1 versions were 
compared to those of plasmid-encoded full length Coi1. The steady state levels of 
coi1-99-114Δ and coi1-103-114Δ were only slightly reduced compared to the full-
length protein, but the levels of coi1-109-114Δ were moderately reduced (Fig 6.11B). 
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Figure 6.10 Conserved residues at the C-terminus of Coi1. Top panel: Schematic 
representation of full length and truncated versions of Coi1 used in this study. Bottom panel: 
Sequence similarity alignment by PSI blast of Coi1 in different fungi 
(https://toolkit.tuebingen.mpg.de /psi_blastp). 
 
Of note, using the anti-Coi1 antibody, no signal could be detected for the truncated 
versions coi1-85-114Δ and 88-114Δ. As a control, the levels of mitochondrial matrix 
protein Ssc1 and Tom40 were not affected by the absence or truncation of Coi1 (Fig 
6.11B). Since the Coi1 antibody was raised against a mixture of two C-terminally 
peptides (81-100 and 101-114 amino acids), it might well be that the lack of detection 
of these versions results from the absence of the appropriate epitopes in these 
proteins.  
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Figure 6.11 Conserved residues at the C-terminus of Coi1 are required for its function. 
(A) WT or coi1Δ cells were transformed with an empty plasmid or with a plasmid encoding 
full length or truncated Coi1. The cells were subjected to a drop dilution assay at the 
indicated temperatures on the specified medium. (B) Crude mitochondria were isolated from 
the strains described in (A). Samples were analyzed by SDS-PAGE and immunodecoration 
with the indicated antibodies. 
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To verify this point, the truncated versions of Coi1 were C-terminally tagged with 
HA. These constructs were ectopically expressed in coi1Δ cells, and a 
complementation assay was performed. In this case, only the coi1-HA-109-114Δ 
partially rescued the growth phenotype of coi1Δ cells, while it was not rescued by the 
other four variants (Fig 6.12A). These findings indicate that the HA-tag has a 
negative effect on the function of the protein. 
 
Figure 6.12 Truncated versions of conserved residues at the C-terminus of Coi1 leads 
to altered function of the protein. (A) WT or coi1Δ cells were transformed with an empty 
plasmid, plasmid encoding full length, or truncated Coi1 with a C-terminally HA-tag. Drop 
dilution assay was performed at the indicated temperatures on the specified medium. (B) 
Crude mitochondria were isolated from strains expressing HA-tagged Coi1 variants in coi1Δ 
cells. Samples were analyzed by SDS-PAGE and immunodecoration with antibodies against 
HA, Ssc1 (mitochondrial matrix protein), and Tom40 (OM protein). 
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The steady state levels of the HA-tagged proteins were also tested in these strains, 
and interestingly, the HA decoration showed that all the truncated versions of Coi1-
HA were expressed at the same levels of the full length Coi1-HA (Fig 6.12B). This 
suggests that the truncation of the different segments at the C-terminal region does 
not affect the expression levels or the stability of the protein. This, in turn indicates 
that the reduced signal observed with the Coi1 antibody is due to the loss of the 
epitopes in the shorter proteins. Therefore, the effects observed on the growth 
phenotype are not due to different protein levels but rather due to altered 
functionality. Taken together, the positively charged amino acid region between 
positions 85 to 99 are essential for the functionality of the protein. 
 
 In vitro import assay to monitor the import of Coi1 into mitochondria 6.5
To better understand the biogenesis of Coi1, an in vitro assay to monitor its 
import into mitochondria was developed. To improve the detection of radiolabeled 
Coi1, four additional methionine residues were added to its C-terminus. The 
radiolabeled precursor protein was precipitated from the reticulocyte lysate and 
refolded in urea containing buffer to remove the abundant hemoglobin, which 
interferes with detection as it has the same molecular weight of Coi1.  
Isolated mitochondria were incubated at 16°C with radiolabeled Coi1 for different 
time points and after the import reaction, mitochondria were re-isolated and subjected 
to PK (Fig 6.13A lane 5-8) or trypsin (Fig 6.13A lane 9-12) treatment to remove non-
imported proteins. As control to test the proteolytic activity on the precursor protein, 
reticulocyte lysate in the absence of mitochondria was subjected to similar PK (Fig 
6.13A lane 1-2) or trypsin (Fig 6.13A lane 3-4) digestion. Such experiments 
demonstrate that radiolabeled Coi1 was protected against PK or trypsin treatment 
with no clear difference between the various time points or the incubation 
temperature tested (4 or 25°C) (data not shown).  
Experiments described above confirmed that Coi1 is an inner membrane protein 
(Fig 6.4B, C). I next aimed to test, if the in vitro imported Coi1 is indeed found in the 
membrane. To differentiate between non-imported (on the surface of mitochondria) 
and imported precursor protein, the mitochondria were re-isolated after import and 
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treated with PK or trypsin with or without Triton X-100. Most of the Coi1 precursor 
proteins was not imported into the mitochondria and was digested by PK or trypsin.  
 
Figure 6.13 In vitro import of Coi1 into wild type mitochondria. (A) Radiolabeled Coi1 
was incubated at 16°C with isolated mitochondria for the indicated time points. At the end of 
the import reactions, mitochondria were re-isolated and treated with proteinase K (PK) or 
trypsin to remove non-imported material. As a control, import reactions lacking mitochondria 
were treated in a similar manner. Imported proteins were analyzed by SDS-PAGE and 
autoradiography. The input lane represents 20% of the radiolabeled protein used in each 
import reaction. (B, C) Mitochondria were incubated at 16°C for 10 min in import reaction, 
and at the end of the import reaction, mitochondria were re-isolated and subjected to PK (B) 
or trypsin (C). In some samples Tx-100 was added to solubilize the organelle. Other samples 
were subjected to alkaline extraction, and the pellet (P) and the supernatant (S) fractions 
were analyzed by SDS-PAGE and autoradiography. 
 
To verify that the protection of Coi1 from external proteases is not resulting from 
aggregation, mitochondria upon import were lysed with Triton X-100 after import. This 
should allow full access to the proteases. Indeed, Coi1 was completely digested in 
presence of trypsin in lysed mitochondria (Fig 6.13C lane 5), whereas with PK it was 
60 
 
only partially digested (Fig 6.13B lane 5). Furthermore, to confirm the insertion of 
Coi1 into the membrane, alkaline extraction was performed to separate membrane 
bound and soluble proteins. In agreement with previous experiments (Fig 6.4B), 
newly imported Coi1 was found in the pellet fraction after alkaline extraction (Fig. 
6.13B- C lane 6).  
In conclusion, Coi1 was not efficiently imported in vitro into isolated mitochondria 
However, a small portion of the molecules reached the IM and remained protease- 
protected and membrane-bound.  
 
 Coi1 forms higher molecular weight complexes  6.6
Next, it was investigated by blue native PAGE whether Coi1 forms a complex 
under native conditions. Isolated mitochondria from wild type, coi1Δ, and a strain 
overexpressing Coi1-HA in coi1Δ background were lysed with 1% digitonin and 
analyzed in 6-13% gel. Although Coi1 has a molecular mass of 12.7 kDa, it could be 
also detected as part of a higher molecular weight complex (Fig 6.14). As Coi1 
antibody had cross-reactive signal with other proteins, samples were also decorated 
with anti-HA antibody. In both decorations, a specific signal for Coi1 at a higher 
molecular mass of approximately 300 kDa could be observed.  
 
Figure 6.14 Coi1 forms higher molecular weight complex. Mitochondria isolated from wild 
type, coi1Δ, and coi1Δ strain overexpressing Coi1-HA were lysed with 1% digitonin, analyzed 
by BNGE and immunodecorated with the specified antibodies. *, indicates cross reactivity of 
the anti-Coi1 antibody. 
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 Deletion of COI1 causes reduction of both the mitochondrial membrane 6.7
potential and oxygen consumption 
6.7.1 coi1Δ cells have reduced mitochondrial membrane potential  
The severe growth phenotype of coi1Δ cells suggests alterations in mitochondrial 
functions (Fig 6.6A). To further study such possible alterations, the membrane 
potential of isolated mitochondria from either wild type or coi1Δ cells was measured 
by employing the membrane potential-sensitive dye DiSc3(5). This fluorescent dye 
undergoes self-quenching upon its migration to energized mitochondria. As 
expected, reduction of the fluorescence signal was observed immediately upon 
addition of mitochondria. This reduction was restored by the addition of the uncoupler 
valinomyin. Of note, the fluorescence quenching was about twofold lower in 
organelles lacking Coi1, in comparison to wild type mitochondria (Fig 6.15). This 
indicates that Coi1 is required for the optimal function of the respiratory complexes.  
 
 
Figure 6.15 Mitochondria lacking Coi1 have lower membrane potential. Membrane 
potential (ΔΨ) of mitochondria isolated from either wild type or coi1Δ cells was monitored by 
a fluorescence assay with the dye DiSC3(5). The first arrow indicates the time point of the 
addition of mitochondria to the dye-containing buffer. The second arrow points to the time 
point when valinomycin was added to dissipate the membrane potential. A reduction of the 
fluorescence signal was observed upon adding mitochondria, which was restored by addition 
of valinomycin. The ΔΨ, represented by the difference in the fluorescence levels before and 
after the addition of valinomycin is indicated. 
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6.7.2 Absence of Coi1 hampers the in vitro import of mitochondrial proteins 
To check if deletion of COI1 affects the biogenesis of other mitochondrial 
proteins, the in vitro import efficiency of newly synthesized radiolabeled precursor 
proteins was analyzed by importing them into organelles isolated from either wild 
type or coi1Δ cells.  
 
Figure 6.16 The absence of Coi1 affects the import of several mitochondrial IM 
proteins. Radiolabeled precursors of Oxa1 (A), AAC (B), F1β (C), and pSU9-DHFR (D) 
were imported for the indicated time periods into mitochondria isolated from either wild type 
or coi1Δ cells. At the end of the import reactions, mitochondria were re-isolated and treated 
with PK to remove non-imported material. Imported proteins were analyzed by SDS-PAGE 
and autoradiography. The input lane represents 20% of the radiolabeled protein used in each 
import reaction. All the experiments were performed in three independent repeats. Bands 
from three independent experiments were quantified and the amount of protein imported for 
the longest time point into control organelles was set to 100%.  
63 
 
Loss of Coi1 reduced the efficiency of the in vitro import of several IM proteins like 
Oxa1, AAC, and F1β, which requires membrane potential for their import (Fig 6.16A- 
C). pSu9-DHFR, a matrix-targeted model substrate with a strong MTS, was not 
affected by the absence of Coi1 (Fig 6.16D). The OM proteins, Porin and Tom40, 
which do not require membrane potential for their import, were not affected by the 
deletion of COI1 (Fig 6.17A, B). These findings suggest that absence of Coi1 affects 
the overall membrane potential and this in turn influences the import efficiency of 
mitochondrial proteins, which are membrane potential dependent.  
 
Figure 6.17 The absence of Coi1 has no effects on the import of mitochondrial outer 
membrane proteins. Radiolabeled precursors of Tom40 (A) and Porin (B) were imported for 
the indicated time periods into mitochondria isolated from either wild type or coi1Δ cells. At 
the end of the import reactions, mitochondria were re-isolated and treated with PK to remove 
non-imported material. Imported proteins were analyzed by SDS-PAGE and 
autoradiography. The input lane represents 20% of the radiolabeled protein used in each 
import reaction. All the experiments were performed in three independent repeats, bands 
were quantified and the amount of protein imported for the longest time point into WT 
organelles was set to 100%. 
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 Deletion of COI1 hampers mitochondrial respiration.  6.8
To substantiate the reduced respiration in the absence of Coi1, mitochondrial 
oxidative phosphorylation was examined by measuring oxygen consumption in wild 
type and coi1Δ cells. These experiments were performed in collaboration with Dr. IIka 
Wittig’s group (Goethe University, Frankfurt) and Prof. Johannes M. Herrmann’s 
group (University of Kaiserslautern). The whole cell oxygen consumption was 
measured by high-resolution respirometry in two steps; first the routine respiration 
was monitored then, the maximal uncoupled respiration. Under both conditions the 
respiration in coi1Δ cells was significantly impaired in comparison to wild type cells 
(Fig 6.18A). Next, the respiration activity of isolated organelles was also measured. 
Reduced respiration capacity in mitochondria lacking Coi1 in comparison to the wild 
type organelles was observed. Of note, mitochondria lacking Coi1 had higher ability 
to respire than non-respiring organelles lacking Oxa1 (Fig 6.18B). This observation 
suggest a residual respiration capacity in coi1Δ cells. Altogether these results 
demonstrate that Coi1 is required for maintenance of the mitochondrial respiration 
activity. 
 
Figure 6.18 Lack of Coi1 affects oxygen consumption. (A) Measurement of oxygen 
consumption in yeast cells. Wild type and coi1Δ cells were grown in YPGal and the oxygen 
consumption was analyzed by high-resolution respirometry at 30°C. Error bars indicate 
standard deviation of three independent experiments. ** p<0.01, *** p<0.001. These results 
were obtained in collaboration with Dr. I. Wittig. (B) Oxygen consumption in mitochondria 
isolated from wild type, coi1Δ, or oxa1Δ cells was measured over time by oxygen 
measurement system at 24°C. These measurements were done in cooperation with the 
group of Prof. J. Herrmann. 
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 Deletion of COI1 influences the steady state levels of mitochondrial 6.9
proteins  
6.9.1 Absence of Coi1 affects the steady state levels of a sub-set of 
mitochondrial proteins 
Lack of Coi1 causes altered mitochondrial function in terms of reduced in vitro 
import of IM proteins and hampered respiration. In order to further investigate the 
effect of COI1 deletion, the steady state levels of proteins in mitochondria isolated 
from coi1Δ cells were monitored. The levels of inner membrane respiratory chain 
complex proteins such as Cox2, Cor1, Qcr6, and Cyb2 were reduced in the mutant 
organelles (Fig 6.19A, B). In addition, the steady state levels of the OM protein OM14 
(Fig 6.20A, B), the matrix protein Aco1, and carrier proteins such as AAC and Pic2 
were affected by the deletion of COI1 (Fig 6.19A, B). 
 
Figure 6.19 Deletion of COI1 affects the steady-state levels of IM proteins. (A) The 
indicated amounts of mitochondria isolated from either wild type or coi1Δ cells were analyzed 
by SDS-PAGE and immunodecoration with the indicated antibodies. (B) The intensity of the 
bands from three independent experiments as those presented in (A) was determined, and 
the amounts of proteins in mitochondria lacking COI1 are presented as mean percentages of 
their levels in wild type organelles. Error bars represent ±s.d.  
 
 
66 
 
In contrast, the levels of mitochondrial outer membrane proteins like Tom40, Tom20, 
and Tom70 as well as inner membrane proteins like Oxa1 and Cox4 or of the matrix 
protein Ssc1 were not affected (Fig 6.19 and 6.20). In conclusion, the absence of 
Coi1 has an effect on the steady state levels of respiratory chain complex proteins 
and some other mitochondrial components. 
 
Figure 6.20 The absence of Coi1 affects some mitochondrial OM proteins. (A) The 
indicated amounts of mitochondria isolated from either wild type or coi1Δ cells were analyzed 
by SDS-PAGE and immunodecoration with the indicated antibodies. (B) The intensity of the 
bands from three independent experiments as presented in (A) was determined, and the 
amounts of proteins in mitochondria lacking Coi1 are presented as mean percentages of 
their levels in wild type organelles. Error bars represent ±s.d.  
 
6.9.2 Coi1 is not involved in translation of mitochondrial encoded proteins 
Steady state levels of mitochondrial-encoded IM proteins were drastically 
reduced in the absence of Coi1. To further investigate the role of Coi1 in the 
biogenesis of such proteins, translation of these proteins in coi1Δ strain was tested 
(in collaboration with Prof. J. Herrmann, University of Kaiserslautern). In either 
galactose or glucose, the translation capacity of mitochondria lacking Coi1 was 
similar or only slightly reduced in comparison to that of control organelles (Fig 6.21). 
Thus, it can be concluded that Coi1 affects the steady state levels of mitochondrial IM 
proteins, but it is hardly involved, or not at all, in the translation of mitochondrial 
encoded proteins. 
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Figure 6.21 Coi1 is not required for mitochondrial-encoded protein synthesis. Wild type 
and coi1Δ cells were grown in rich media containing galactose (gal) or glucose (glu). Cells 
were re-suspended in synthetic medium lacking methionine and treated with cycloheximide 
to block cytosolic translation. Radiolabeled methionine was added and cells were incubated 
at 30°C. At the indicated time points samples were subjected to alkaline extraction and 
analyzed by SDS-PAGE followed by autoradiography. The translated mitochondria proteins 
are indicated on the margin. These results were obtained in collaboration with the group of J. 
Herrmann. 
 
 Interaction partners of Coi1 6.10
6.10.1 Coi1 physically interacts with components of complexes III and IV  
Our aforementioned results demonstrate that the absence of Coi1 affects the 
levels of some respiratory components and respiration activity. In search of 
interaction partners of Coi1, a yeast strain expressing C-terminally HA tagged Coi1 
was generated, and the functionality and the correct location of this tagged version 
was verified (Fig 6.6B). Isolated mitochondria from this strain were solubilized with 
various detergents such digitonin (1%), DDM (0.5%), or Triton X-100 (0.5%). Affinity 
purification was performed using anti-HA magnetic beads. Interestingly, various 
components of complex III (Cor1, Qcr6), complex IV (Cox2, Cox4), the carrier protein 
Pic2, and the contact site protein, Mic60 were co-eluted with Coi1-HA (Fig 6.22A-C).  
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Figure 6.22 Coi1-HA interacts with components of complexes III and IV. Mitochondria 
were isolated from either wild type or coi1Δ cells expressing Coi1-HA. The organelles were 
lysed with buffer containing 0.5% Triton X-100 (A), 0.5% digitonin (B), or 0.5% DDM (C). The 
lysates were subjected to a clarifying spin, and the supernatants were used in a pull-down 
assay with anti-HA magnetic beads. Supernatant (In, 2% of total), unbound material (Un, 2% 
of total), and material eluted from the beads (E, 33.3% of total) were analyzed by SDS-PAGE 
and immunodecoration with the indicated antibodies. 
69 
 
These interactions with Coi1 were specific, as they were not observed in the control 
strain. Furthermore, other mitochondrial proteins such as the soluble matrix protein 
Aco1, the IM protein Tim23, complex V protein Tim11, and the OM protein Tom22 
were not co-eluted with Coi1-HA (Fig 6.22A-C). Interestingly, the interaction between 
Coi1 and the partners was very stable even in a harsh detergent such as Triton X-
100. These findings suggest that Coi1 physically interacts with subunits of complexes 
III and IV.  
 
6.10.2 The interactome of Coi1 as analyzed by mass spectrometry 
To obtain a more comprehensive picture of the interactome of Coi1, proteins 
interacting with Coi1-HA were analyzed by mass spectrometry. This analysis was 
done in collaboration with Dr. IIka Wittig’s group (Goethe University, Frankfurt). 
Affinity pull-downs were performed as mentioned in section 6.10.1 using 
mitochondria isolated from either wild type or coi1Δ cells expressing Coi1-HA that 
were solubilized with 0.5% Triton X-100. Proteins interacting with Coi1-HA were 
digested with trypsin and analyzed by liquid chromatography and mass spectrometry. 
The data from the mass spectrometric analysis is plotted on volcano plot, and the 
proteins were sorted to 0.03 false discovery rate (FDR) showing highly significant 
interaction partners of Coi1 (Fig 6.23). In agreement with the previous results (Fig 
6.22), the volcano plot demonstrated that components of complexes III and IV like 
Qcr1, Qcr2 (complex III), Cox2 (complex IV), and Rcf1 (regulator factor of 
supercomplex III-IV) are highly enriched in the group of strong interactors of Coi1. 
Interestingly, the central component of the TOM complex, Tom40 also appears to 
interact with Coi1-HA (Fig 6.23), in contrast to what previously shown (Fig 6.22). 
However, this interaction probably represents an import intermediate when newly 
synthesized molecules of Coi1 are translocated via the TOM complex. Taken 
together, the mass spectrometry analysis confirms that Coi1 interacts with 
components of the respiratory chain complexes. 
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Figure 6.23 Coi1 interacts with respiratory chain complex proteins. Mitochondria 
isolated from coi1Δ cells expressing Coi1-HA were solubilized with 0.5% Triton X-100 and 
subjected to affinity purification. Eluted fractions were trypsinized and analyzed by 
quantitative mass spectrometry. The log fold change and the negative log10 p-value of six 
independent experiments were determined and plotted. Proteins belonging to the same 
complex are shown in the same color; complex III subunits in red, complex IV subunits in 
green, assembly factors of complex III in pink, assembly factors of IV in blue, and biogenesis 
factors in black. 
 
6.10.3 Mic60 stabilizes the interaction between respiratory chain complexes 
and Coi1 
An interesting finding from the affinity pull-down assays was that the central 
subunit of the mitochondrial contact site complex (MICOS), Mic60 was also co-eluted 
with Coi1-HA. To understand the relevance of this physical interaction, affinity pull-
down with a strain expressing Coi1-HA in the absence of Mic60 was performed as 
described in section 6.10.1. Surprisingly, in the absence of Mic60, the interactions 
between Coi1-HA and its partners were drastically reduced (Fig 6.24). Of note, the 
HA-tagged form of Coi1, brings down also the native form of the protein suggesting 
that the Coi1 containing functional unit harbors at least two copies of the protein. This 
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interaction was also reduced in the absence of Mic60. Collectively, it appears that 
Mic60 is stabilizing, directly or indirectly, the interactions of Coi1 with its partner 
proteins. 
 
Figure 6.24 Mic60 stabilizes the interactions of Coi1 with its partner proteins. 
Mitochondria were isolated from either wild type or mic60Δ cells expressing Coi1-HA. 
Organelles were treated as described in section 6.10.1. Supernatant (In, 2% of total), 
unbound material (Un, 2% of total), and material eluted from the beads (E, 50% of total) were 
analyzed by SDS-PAGE and immunodecoration with the indicated antibodies. * indicates 
detection of HA-tagged Coi1 with anti-Coi1 antibody. 
 
 The importance of Coi1 for the formation of supercomplexes 6.11
6.11.1 Coi1 plays an important role in the formation and stability of respiratory 
supercomplexes 
The aforementioned results suggest strong physical and functional interactions 
between Coi1 and complexes III and IV. To investigate whether Coi1 is involved in 
regulation of the assembly or stability of these complexes, they were examined by 
blue native PAGE (in collaboration with Dr. Ilka Wittig, Goethe University, Frankfurt). 
BN-PAGE of organelles solubilized in digitonin revealed that the absence of Coi1 
resulted in reduced levels of complex IV and its super complexes with complex III 
72 
 
(Fig 6.25). To further confirm the defect in complex IV, a specific heme staining was 
performed. In the absence of Coi1, complex IV in its monomeric form or as a part of 
supercomplexes exhibited almost no heme staining, pointing to an impaired complex 
IV assembly or heme integration (Fig 6.25B).  
 
Figure 6.25 Coi1 is essential for assembly of complexes III and IV and their 
supercomplexes. Mitochondria isolated from wild type and coi1Δ cells were analyzed by 
blue native PAGE. (A) Samples were solubilized using 2.5% digitonin and the gels were 
stained with Coomassie. (B) Samples were analyzed as in (A) and the complex IV was 
detected by a specific heme staining. (C, D) Samples were analyzed as in (A) and then 
immunodecorated with antibodies against either the complex IV subunit Cox26 (C) or the 
complex III component Rip1 (D). Black annotations describe yeast complexes and blue 
annotations represent a mass ladder of mitochondrial complexes from bovine heart 
mitochondria (BHM). Complexes and proteins marked in grey highlights the altered 
appearance of supercomplexes III2IV1 (*), III2IV2 (**), Rieske protein of complex III (Rip1), 
complex IV and its assembly intermediates (Int1cox, Int2cox), complex III and its assembly 
intermediate (Int3bc1). Assignment of mitochondrial complexes: V1 and V2, monomeric and 
dimeric ATP synthase; III2, dimeric complex III; IV1, monomeric complex IV; III2IV1, 
supercomplex containing complex III dimer and one copy of complex IV; III2IV2, 
supercomplex with two copies of complex III and two of complex IV; S1, mammalian 
supercomplex containing complex I, two complex III, and one copy of complex IV. 
 
The complexes were further analyzed by immunodecoration with antibodies 
against subunits of either complex IV (Cox26) or complex III (Rip1) (Fig 6.25C, D). 
The results indicated alterations in these complexes upon deletion of COI1. Cox26 
was detected in two weak bands (Int1cox and Int2cox) in the migration range of 
monomeric complex IV, and a size shift was observed in the supercomplexes (Fig  
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6.25C). In addition to the size shift, a considerably lower amount of supercomplexes III/IV 
were detected. These observations indicate assembly problems in the absence of Coi1 
that are manifested as an altered composition or a dead-end assembly intermediate.  
Complex III was also analyzed by immunodecoration with antibody against Rip1. 
Similarly, a defect in assembly of complex III subunits in absence of Coi1 was 
observed (Fig 6.25D). Deletion of COI1 resulted in lower abundance of complex III 
dimers (Int3bc1) and supercomplexes III/IV, as well as in change in their migration 
behavior. In line with reduced assembly, an accumulation of Rip1 monomer was 
detected in the absence of Coi1 (Fig 6.25D).  
 
6.11.2 Overexpression of Coi1 rescues the assembly defect of respiratory 
chain complexes 
Since the overexpression of either Coi1 or Coi1-HA rescues the growth 
phenotype of coi1Δ cells (Fig 6.7), I wondered whether such overexpression would 
also reduce the altered assembly of the supercomplexes III2IV2 (Fig 6.25). Isolated 
mitochondria from wild type, coi1Δ, and coi1Δ overexpressing Coi1-HA cells, were 
solubilized with 1% digitonin and analyzed by blue native PAGE. The gels were either 
stained with Coomassie or immunodecorated with antibodies against complex III or 
IV subunits. In absence of Coi1, almost no Coomassie staining was observed at the 
levels of supercomplexes, while overexpressed Coi1 could restore the levels of 
supercomplexes back to wild type amounts (Fig 6.26A).  
Additionally, immunodecoration against the core complex IV subunit (Cox2) 
revealed that, Cox2 was not assembled into monomeric complex state and the 
supercomplexes in the absence of Coi1. Overexpression of Coi1 reversed these 
effects (Fig 6.26B). The absence of Coi1 had similar influence on complex III (Cor1), 
and overexpression of Coi1 reversed the levels of III2IV2 supercomplex (Fig 6.26C). 
To control for specificity, absence of Coi1 has no influence on the assembly of the 
TOM complex (Fig 6.26D). These observations clearly show that overexpressed Coi1 
can rescue altered assembly of supercomplexes and monomeric complex IV in 
mutant cells. This rescue capacity demonstrates that the observed alterations are 
direct outcome of the absence of Coi1.  
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Figure 6.26 Overexpression of Coi1 in coi1Δ cells rescues the assembly of III2IV2 
supercomplexes. Isolated mitochondrial from the indicated strains were lysed with 1% 
digitonin and analyzed by blue native PAGE. Gels were stained with Coomassie (A), or 
immunodecorated with specific antibodies against the core subunit of complex IV, Cox2 (B), 
the Cor1 subunit of complex III (C), or the central TOM component, Tom40 (D). 
 
 Coi1 is required for the function of complex IV 6.12
6.12.1 Lack of Coi1 reduces complex IV activity 
The results described above suggest that the altered monomer complex IV and 
supercomplex formation in the absence of Coi1 lead to respiratory defects. Next we 
asked whether the presence of Coi1 is required for the enzymatic function of complex 
IV. To that goal the activities of cytochrome c oxidase (COX) and citrate synthase 
(CS) as a control were measured (in collaboration with Dr. Ilka Wittig’s group, Goethe 
University, Frankfurt). The enzymatic activity of COX and CS were measured in 
isolated mitochondria from either wild type or coi1Δ cells. Since CS activity (Fig 
6.27B) was slightly affected, COX activity was normalized to the CS activity. In 
mitochondria lacking Coi1, COX activity was significantly reduced compared to wild 
type mitochondria (Fig 6.27A). This finding suggests an essential role for Coi1 in 
normal function of complex IV.  
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Figure 6.27 Coi1 is required for function of complex IV. Enzymatic activity of Cytochrome 
c Oxidase (COX) (A) and Citrate Synthase (CS) (B) were analyzed by spectroscopy at 30°C 
in mitochondria isolated from either wild type or coi1Δ cells. Error bars indicate standard 
deviation of three independent experiments. *** p<0.001 (Student t-test). 
 
6.12.2 Coi1 is required for the optimal assembly of heme A into complex IV  
The altered assembly of complexes III and IV in organelles lacking Coi1 (Fig 
6.25) and the absence of heme staining of complex IV (Fig 6.25 B) led us to 
investigate the heme absorbance spectra in these organelles. Interestingly, the 
intensity of absorbance of heme types B and C were higher in the organelles from the 
mutated cells as compared to control mitochondria (Fig 6.28).  
 
 
Figure 6.28 Coi1 is required for the optimal assembly of the heme A into complex IV. 
The absorbance spectra of different heme types was measured in mitochondria isolated from 
either wild type or coi1Δ cells. Heme C, B, and A are detected at wavelengths of 551, 561, 
and 603 nm, respectively.  
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In contrast, heme A absorbance was drastically reduced in the absence of Coi1. 
Collectively, the heme staining results and the heme absorbance measurements 
suggest that Coi1 is required for the proper transfer of heme A to complex IV and/or 
the assembly of heme A into this complex.  
 
6.12.3 The putative heme binding domain of Coi1 is not crucial for its function  
To investigate the relevance of Coi1 for heme assembly, the amino acid 
sequence of Coi1 was screened for a possible heme binding domain. Heme binding 
domains usually consist of the motif CXXCH, but it was also reported that the motifs 
CXXXH or XXCH, lacking one of the two cysteines of the classical heme binding 
motif, can still lead to a transient interaction with heme (Allen et al., 2004; Mavridou 
et al., 2012). Interestingly, CXXXH motif (residues 77 to 81) was identified in Coi1. To 
investigate the role of these amino acids in the function of Coi1, single point 
mutations replacing either cysteine at position 77 by serine (C77S) or histidine at 
position 81 alanine (H81A) as well as the double replacement were introduced (Fig 
6.29A). Coi1 versions containing the single or double mutations were expressed in 
yeast cells lacking the native protein and the steady state levels of the Coi1 variants 
were analyzed. The mutations had no effect on the protein levels of Coi1 when 
compared to the native protein (Fig 6.29B). Next, the rescue capacities of the 
different mutated Coi1 versions were analyzed by a drop dilution assay (Fig 6.29C). 
Both variants with single mutant and the one with the double replacement could 
rescue the growth phenotype of coi1Δ cells to a similar extent as the native protein 
(Fig 6.29C). Taken together, the putative heme binding domain in Coi1 does not play 
a major role in the function of the protein. 
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Figure 6.29 CXXXH motif in Coi1 has no direct functional role. (A) Schematic 
representation of the mutations performed at the putative heme binding domain in Coi1 
sequence. Cysteine 77 was mutated to serine (C77S), histidine 81 to alanine (H81A). The 
sequence of the canonical heme binding motif is indicated. (B) Crude mitochondria was 
isolated from the indicated strains. Proteins were analysis by SDS-PAGE and 
immunodecoration with the specified antibodies. (C) Cells lacking Coi1 were transformed 
with an empty plasmid or plasmid encoding full length Coi1, single mutant (C77S and H81A) 
or double mutant (C77S/H81A). The growth on the specified medium of the transformed cells 
and WT as control was monitored at the indicated temperatures by drop dilution assy.  
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7 Discussion 
The mitochondrial respiratory chain complexes are arranged in series of 
supercomplexes for their flawless functions. These multifaceted structures are 
assembled by an array of factors bringing the individual complexes together to a 
working state. Although several such assembly factors have been identified and 
characterized, the complete picture of the assembly process as well as a 
comprehensive list of the proteins involved are still lacking. In the current study we 
identified a novel protein Coi1 that is required for the assembly of the respiratory 
chain supercomplexes. 
 
 Coi1 is a small single transmembrane domain protein 7.1
Coi1 is a small protein with a molecular mass of 12.7 kDa that is conserved in 
fungi but has no apparent homologues in higher eukaryotes. From in silico prediction, 
Coi1 has a putative transmembrane segment in its N-terminal region (a.a. 11-30). 
The experiments performed in this study suggest that Coi1 has indeed a 
transmembrane domain that is embedded in the IM. The short N-terminal region of 
Coi1 is facing the matrix and the C-terminal domain resides in the IMS. Some of the 
IM precursor proteins contain an N-terminal targeting sequence which directs them to 
the TIM23 machinery (Fig 3.1) (Becker et al., 2012; Dudek et al., 2013). IM proteins 
are also sorted by hydrophobic internal signal which is laterally released into the 
membrane by the TIM23 complex (Diekert et al., 1999; Rehling et al., 2003). Coi1 
has no predicted canonical cleavable presequence, but might be target with internal 
targeting signal, which remains unknown. To better understand the targeting of Coi1, 
I constructed different truncated versions of Coi1 (Fig 6.8). These experiments show 
that the transmembrane domain of Coi1 is crucial for the correct topology and 
stability of the protein. However, whether the transmembrane domain is also required 
for the targeting of Coi1 to mitochondria remains unclear. Nevertheless, I could show 
that the first nine amino acids of Coi1 are not essential for the correct targeting of the 
protein, as the corresponding truncated version of Coi1 (coi1-2-9Δ) is targeted to and 
inserted into the mitochondrial IM.  
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 Structural organization of Coi1 7.2
According to multiple sequence alignment, the hydrophilic C-terminal region of 
Coi1 has relatively low sequence conservation but contains highly charged amino 
acids which are conserved in various species (Fig 6.10). To understand the 
relevance of these conserved segments, truncated versions lacking them were 
generated. Nearly all truncated versions have a severe impact on the function of Coi1 
as they were not able to rescue the growth phenotype of coi1Δ cells expect from 109-
114 (coi1-109-114Δ), which would partially complement the coi1Δ phenotype (Fig 
6.11A, B). Steady state levels of truncated versions of Coi1 beyond 85-114Δ and 88-
114Δ were not able to be detected by anti-Coi1, due to loss of recognition site 
(antibody was raised against 81-100 and 101-114 amino acids peptides) (Fig 6.11B). 
Therefore proteins levels were compared to HA-tagged variants. Notably, the protein 
levels of truncated version with HA-tag were similar to full length protein, suggesting 
that the removed segments are not crucial for the stability of the protein (Fig 6.12B). 
The positively charged amino acid region might play a structural role in Coi1 or 
potentially involved interacting with the other proteins containing patches of 
negatively charged residues of its function. Another speculation might be that 
positively charged residues of Coi1 may interact with polar head groups of lipids.  
 Coi1 interacts with respiratory complexes III and IV that are composed from core 
subunits and accessory subunits (Fig 6.22). These accessory subunits are mostly 
small nuclear-encoded proteins, which assist in the regulation, assembly or 
stabilization of respiratory chain complex subunits (Zickermann et al., 2010). The 
amino acid sequences of these subunits are relatively low conserved between 
mammals and yeast, and also some subunits are completely absent in other 
eukaryotes (Das et al., 2004). Despite their low sequence similarity, several small 
subunits of the respiratory chain complexes with a molecular mass ranging from 6 to 
19 kDa are predicted to have a common topology. These subunits are mainly integral 
membrane proteins containing a hydrophobic α-helical region buried in the 
phospholipids core of the membrane and soluble, hydrophilic domains at the N- and 
C-termini (Zickermann et al., 2010). The hydrophilic region of these subunits contains 
an unusually high percentage of charged residues. For example, the bovine ATP 
synthase e, f, and k subunits contain around 50% of charged residues in their C-
terminal domains (McCaldon and Argos, 1988; Turakhiya et al., 2016; Zickermann et 
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al., 2010). Coi1 has a similar topology as a single-span protein. Around 34% of 
Coi1’s sequence is made up of aspartate, glutamate, lysine or arginine. These 
residues are especially enriched in the hydrophilic, C-terminal region that resides in 
the IMS. The lack of Coi1 homologues in higher eukaryotes is also not an unusual 
feature of the accessory factors. Collectively, Coi1 shares several structural features 
with other accessory subunits of respiratory complexes such as membrane topology 
and amino acid composition point to a possible role of Coi1 as an of accessory 
subunit of the respiratory chain complexes.  
 
Figure 7.1 Mic60 retains the cristae junction and its architecture. Cristae organizing 
system (MICOS) is a multi-subunit complex which is enriched in cristae junctions. Mic60, 
which is a core subunit of MICOS complex is essential for normal cristae architecture. Mic60 
complex forms contacts with the outer membrane by interactions with Tom40 and SAM. In 
wild type condition when Mic60 is present, Coi1 interacts with respiratory chain complexes. 
In the absence of Mic60, the interactions between Coi1 and the respiratory chain complexes 
are drastically reduced. Such a reduction might affect the assembly of respiratory 
supercomplexes. 
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The deletion of COI1 results in cell growth retardation, dissipation of the 
mitochondrial membrane potential, and defects in oxidative phosphorylation activity. 
To better characterize the precise function of Coi1, I searched for its interaction 
partners. Affinity pull-down experiments showed that Coi1 interacts with various 
components and assembly factors of the respiratory chain complexes III and IV, with 
the contact site protein Mic60, with carrier proteins, and with the OM protein Tom40 
(Fig 6.22). The strongest interaction partners of Coi1 were Qcr1, Qcr2, Cox2, Rcf1, 
and Tom40 (Fig 6.23). In another study, Coi1 was also identified in the interactome of 
Cox4 (Bottinger et al., 2013), confirming the interaction of Coi1 with Complex IV. 
Interestingly, I could show that Coi1 interacts with Mic60, which is a core component 
of the MICOS complex in the IM (Friedman et al., 2015). Furthermore, I also 
observed that the interactions of Coi1 with the respiratory complexes subunits were 
weaker in the absence of Mic60 (Fig 6.24). A potential explanation for this effect is 
that Mic60 facilitates the optimal positioning of the respiratory complexes and Coi1, 
and thus contributes for their interactions (Fig 7.1). In line with my findings, recent 
studies have shown that the MICOS complex is required for efficient function of 
respiratory chain complexes in both yeast and mice (Cogliati et al., 2013; Friedman et 
al., 2015). 
 
 Coi1 is required for the formation of complexes III and IV and of their 7.3
supercomplexes  
The interaction of Coi1 with the respiratory chain complexes were confirmed by 
blue native PAGE. We noticed that the absence of Coi1 results in defects in the 
assembly of complexes III and IV. Accordingly, the non-assembled form of the 
complex III subunit Rip1 was detected in much higher amounts in mitochondria 
lacking Coi1 (Fig 6.25). Moreover, a considerable shift in the apparent molecular 
weight of complex III and IV supercomplexes was observed in organelles lacking 
Coi1, which might be a result of the accumulation of a stalled intermediate complex 
IV. In addition to this shift, lower amounts of the complex III and IV supercomplexes 
were observed (Fig 6.25). Heme was detected only at the levels of the 
supercomplexes suggesting that maybe the affinity of the complex subunits to heme 
is higher when complex IV is part of a supercomplex (Fig 6.25B). Taken together, the 
deletion of COI1 leads to altered levels of complexes III and IV of the respiratory 
chain.  
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The absence of Coi1 seems to impair the final step of complex III assembly 
possibly leading to a dead-end assembly intermediate. Furthermore, the lack of Coi1 
causes also a major reduction in the amounts of heme associated with complex IV. 
Considering these observations, Coi1 resembles Rcf1 and Rcf2 that mediate 
supramolecular interactions between complex III and IV. Interestingly, both Coi1 and 
Rcf2 are found only in fungi (Strogolova et al., 2012). The results from interaction 
studies show a clear physical and functional interaction of Coi1 with the respiratory 
chain complexes III and IV. Hence, Coi1 might work in a similar fashion as Rcf1 and 
Rcf2 to regulate the assembly and stability of respiratory chain supercomplexes. 
 
7.3.1 Coi1 might provide heme to complex IV 
The absence of Coi1 leads to a clear reduction of heme staining and heme A 
absorbance of complex IV. This raises the possibility that Coi1 facilitates the 
incorporation of heme into complex IV. Heme is a crucial cofactor of many oxidases 
in eukaryotic cells, and heme A, which is typical to complex IV, is synthesized with 
the help of Cox10 (heme O synthase) (Tzagoloff et al., 1993) and Cox15 (heme A 
synthase) (Barros et al., 2002). Heme A is required for the proper folding of Cox1, a 
core subunit of complex IV, and it also stabilizes the interaction between Cox1 and 
other subunits of complex IV (Kim et al., 2012). The results in this study show 
moderate changes in the absorbance of heme B and C whereas the absorbance of 
heme A was dramatically diminished (Fig 6.28). These findings suggest a dramatic 
loss of this redox cofactor and might indicate a potential defect in the synthesis of 
heme A.  
The process that assures heme insertion into the mature Cox1 is not resolved 
yet. Cox1 is assembled co-translationally into the IM and it forms an intermediate 
complex with chaperones (Cox14, Cox25, and mitochondrial matrix Ssc1), assembly 
factors (Coa1, Coa2, Coa3, and Shy1), and complex IV subunits (Cox5a and Cox6). 
At this stage, heme seems to be incorporated in the vicinity of Shy1 (Bareth et al., 
2013; Kim et al., 2012; Mashkevich et al., 1997). The absence of the assembly 
factors and chaperones mentioned above affects the assembly of the Cox1 
intermediate complex (Khalimonchuk et al., 2010; Kim et al., 2012). In the current 
study, it is observed that in the absence of Coi1, mitochondrially encoded proteins 
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are normally translated (Fig 6.21), but their assembly into functional complexes is 
impaired (Fig 6.25).  
The observed defects in the assembly of these proteins might be due to an 
impaired heme association. One can speculate that Coi1 might be directly or 
indirectly involved in the incorporation of heme into mature Cox1. A possible 
connection of Coi1 to heme is the sequence motif CXXXH (77- 81 aa) present in the 
C-terminal domain of the protein. CXXCH is known as a C-type heme binding motif, 
where the two cysteine residues interact with the vinyl carbon groups of heme and 
the single histidine binds the heme iron (Allen et al., 2004; Kim et al., 2012; Mavridou 
et al., 2012). It was also reported, that the presence of only a single cysteine, as it is 
the case in Coi1, leads to an intermediate affinity to heme (Fulop et al., 2009). The 
mutagenesis experiments performed in this study showed that the putative heme 
binding domain might not have direct functional role in heme binding. Therefore, it is 
possible that Coi1 is not directly involved in transferring heme to complex IV, but 
might be involved together with other proteins to direct heme to its final destination. 
Based on the results presented above, the phenotype of the deletion of COI1 
could be explained by the following model (Fig 7.2 and 7.3). In the absence of Coi1, 
heme A is not incorporated into the early Cox1 containing complex which leads to a 
stalled intermediate complex comprising also the mitochondrial ribosome and Mss51. 
Due to the accumulation of the ribosome and other subunits, a size shift of complex 
is detectable by blue native PAGE (Fig 6.25). Mss51 is an important negative 
feedback regulator of Cox1 translation, which might inhibit the Cox1 translation 
leading to defective Cox1 intermediate assembly.  
According to the experiments performed in this study, Coi1 might have a second 
function in assembling the supercomplexes formed between complex III and IV. Lack 
of Coi1 clearly leads to a growth phenotype on non-fermentable carbon sources (Fig 
6.6) and a drastic reduction of complex IV activity (Fig 6.27). Furthermore, the 
deletion of COI1 has a severe effect on the III2IV2 supercomplex and on complex IV, 
which can be complemented by ectopically expressed Coi1 (Fig 6.26). Considering 
the physical interaction between Coi1 and Rcf1, Coi1 might help Rcf1 as interface 
between complexes III and IV. 
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Figure 7.2 Coi1 is required for heme insertion in complex IV. Cox1 is synthesized in the 
mitochondrial matrix while the translating ribosomes are activated by the translational 
activator Mss51. Oxa1 inserts Cox1 into the IM and interacts with Cox14 and cytochrome c 
oxidase assembly 3 (Coa3) factor. Cox15 is involved in biogenesis of heme A, it converts 
heme O to heme A in the matrix. Cox15 interacts with crucial cofactor of COX such as Coa3, 
Cox14 and Shy1. (1) In wild type mitochondria, Coi1 interact with Cox15 and cofactor 
involved in Cox1 biogenesis. Coi1 might be involved in the insertion of heme A into Cox1 
with cooperation with other cofactors. This pre-assembly step leads to further insertion of 
nuclear encoded subunits to form a mature complex IV. The export of heme A from the 
matrix to the IMS remains still unclear, therefore it is indicated with a question mark (?). (2) In 
absence of Coi1, heme A is not completely available to Cox1 intermediate complex 
suggesting a stalled COX complex with assembly cofactors and mitochondrial ribosomes. 
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So far it was shown that Rcf1 and Rcf2 are required for the stability of the III2IV2 
supercomplex and for the assembly of Cox13, which might be the link between Rcf1 
and the complexes III and IV (Strogolova et al., 2012; Vukotic et al., 2012). Taken 
together, Coi1 might assist in the assembly of complex IV and interact with Rcf1 or 
Rcf2 to help them to form the respiratory chain supercomplexes. 
Regardless of its actual molecular mechanism, this study identifies Coi1 as a 
novel assembly factor essential for the proper function of the mitochondrial 
respiration.  
 
 
 
Figure 7.3 Suggested models for the involvement of Coi1 in supercomplex formation. 
Upper part: In WT cells Coi1 and Rcf1 help to form supercomplexes of complex III and 
complex IV. Lower part: Deletion of COI1 can lead to unassembled supercomplex and the 
coexistence of different pools such as (1) partially assembled supercomplexes, (2) altered 
structure of assembled supercomplexes, or (3) stalled assembly of complex IV due to defects 
in heme integration. *, stalled complex IV; **, altered supercomplex. 
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